Skip to main content
American Journal of Cancer Research logoLink to American Journal of Cancer Research
. 2020 Jul 1;10(7):2010–2031.

Principles and treatment strategies for the use of Chinese herbal medicine in patients at different stages of coronavirus infection

Sheng-Teng Huang 1,2,3,4, Hsiang-Chun Lai 2, Yu-Chun Lin 2, Wei-Te Huang 2, Hao-Hsiu Hung 2, Shi-Chen Ou 2, Hung-Jen Lin 1,2, Mien-Chie Hung 5
PMCID: PMC7407358  PMID: 32774998

Abstract

Coronavirus disease 2019 (COVID-19) is a novel, human-infecting β-coronavirus enveloped, positive-sense single-stranded RNA viruses, similar to the severe acute respiratory syndrome (SARS) infection that emerged in November 2002. In traditional Chinese medicine (TCM), the epidemic disease concepts of “febrile epidemics” (wenyi) or “warm diseases” (wenbing) are based on geographic and cultural aspects, and Chinese herbal medicine (CHM) played an important role in the treatment of epidemic diseases. CHM was widely used to treat patients suffered with SARS almost two decades ago during outbreak of SARS, with proven safety and potential benefits. TCM has also been widely used to treat cancer patients for a long history and much of them associate with immunomodulatory activity and are used to treat coronavirus-related diseases. We propose the use of CHM treatment principles for clinical practice, based on four main stages of COVID-19 infection: early, intermediate, severe, and convalescence. We suggest corresponding decoctions that exhibit antiviral activity and anti-inflammatory effects in the early stage of infection; preventing the disease from progressing from an intermediate to severe stage of infection; restoring normal lung function and improving consciousness in the severe stage; and ameliorating pulmonary and vascular injury in the convalescent stage. We summarize the pharmaceutical mechanisms of CHM for treating coronavirus via antiviral, anti-inflammatory and immunomodulatory effects.

Keywords: Coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome (SARS), traditional Chinese medicine (TCM), Chinese herbal medicine (CHM), febrile epidemics (wenyi), warm diseases (wenbing)

Introduction

After first emerging in Foshan, Guangdong Province, mainland China, in November 2002, severe acute respiratory syndrome (SARS) developed within months into a worldwide epidemic, infecting more than 8,000 patients and causing 774 deaths throughout 26 countries [1]. In December 2019, another infectious disease emerged in Wuhan city, Hubei province, China, which was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initially known as the Wuhan pneumonia and then labeled as Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). As of late May 2020, the total number of confirmed COVID-19 cases is about 5 million, and more than 300,000 deaths have been reported worldwide [2].

Coronavirus and transmission of COVID-19

COVID-19 is a novel, human-infecting β-coronavirus enveloped, positive-sense single-stranded RNA viruses that shares high similarity with bat coronavirus. Although the genome sequences of COVID-19 are fairly distant from SARS-CoV (with ~79% identity), homology models have revealed that COVID-19 has a similar receptor-binding domain structure of angiotensin-converting enzyme 2 (ACE2) to that of SARS-CoV [3].

Person-to-person transmission of COVID-19 infection was confirmed by infected family members and medical workers [4,5]. Direct contact occurs due to close exposure to coughing, sneezing, respiratory droplets or aerosols produced by an infected person; indirect contact occurs via environmental or fomite contamination [6]. Symptoms of cough and fever are most common in patients with COVID-19, with other symptoms such as dyspnea and myalgias in mildly infected patients [7], however, predominantly gastrointestinal symptoms (diarrhea, nausea and vomiting) have been reported from hospital patients in New York city [8]. In clinical practice, an epidemiological history and clinical manifestations are the main diagnostic basis of COVID-19 infection, combined with other significant examinations such as chest CT radiography and nucleic acid detection, where real-time quantitative polymerase chain reaction (RT-qPCR) or high-throughput sequencing are commonly used [9]. However, only supportive therapeutic strategies are currently available for treating COVID-19 infection [10]; no specific antiviral drugs or vaccines are available as yet [11].

COVID-19 infection in cancer patients

Patients diagnosed with cancer are more susceptible to COVID-19 infection and have higher risks of developing severe events compared with those without cancer, and those who underwent chemotherapy or surgery in the past months even presented a numerically higher risk [12]. Cancer patients with hematologic cancer, lung cancer, or with metastatic cancer were more vulnerable to SARS-CoV-2 infection and, thus, associated with worse clinical outcomes [13]. The immunocompromised status might be the cause of COVID-19 infection in the patients with cancers [14]. Contact avoidance of hospital visit and admission were proposed for those patients in the French High Council for Public health (HCSP) guideline [15] and the other Chinese study [16] to reduce their risk of infection, which means anticancer treatment might be discontinued or schedule adjustment for cancer patients during the pandemic.

Another very interest link between cancer and COVID-19 is the human TMPRSS2, a key host cell protease for the SARS-CoV-2 virus to enter host cells is known to be activated in prostate cancer through TMPRSS2-ERG fusion gene [17,18]. Thus, TMPRSS2 inhibitors could be anti-cancer and anti-COVID-19 drugs. In addition, many key enzymes that control SARS-CoV-2 replication including 3-CL protease (also named Mpro), papain-like protease and replicase, etc. have been used as therapeutic targets to develop anti-COVID-19 drugs. The approach and concept are virtually identical to target therapy for cancer precision medicine.

The role of Chinese herbal medicine (CHM) in the treatment of coronavirus

In Traditional Chinese Medicine (TCM), the epidemic disease concepts of “febrile epidemics” (wenyi) and “warm diseases” (wenbing) are based on geographic and cultural aspects, and CHM played an important role in the treatment of epidemic diseases [19]. More recently, TCM was widely used for treating SARS, with proven safety and potential benefits. Patients infected with SARS-CoV who were administered CHM treatment experienced improvements in symptoms, increased lung infiltrate absorption, lower glucocorticoid and antiviral consumption, fewer side effects, and shorter hospital admission durations [20,21]. As for cancer patients, CHMs also exert antitumor effects by regulating immune response [22] which might be beneficial to reduce the risk of coronavirus infection. In this article, we propose the use of CHM treatment principles for clinical practice, based on four main stages of COVID-19 infection: early, intermediate, severe, and convalescence. The pharmaceutical mechanisms of CHM in the treatment of coronavirus are summarized in Tables 1 and 2. And the Chinese characters and pronunciations (pinyin) of syndromes in every stage are listed in Supplementary Table 1.

Table 1.

Pharmaceutical mechanisms of Chinese herbs in treating coronavirus, based on study types conducted during different stages of the disease

Stages Chinese herbs Latin name Clinical trial Animal study In vitro study
Early Jinyinhua Flos Lonicerae Japonicae shorten fever period [24] antiviral activity [30] neuraminidase inhibitory activity [30-32]
increase nuclear Sp1 binding activity and IL-10 expression of IL-10 [36] antiviral activity [33]
decrease nuclear NF-κB binding activities, TNF-α, IL-1β and IL-6 in the lung [36]
suppress Toll-Like Receptor 4 signaling [34]
inhibit lymphocyte apoptosis [35]
anti-inflammatory and antioxidative activities in alveolar macrophages [28]
Early and intermediate Lianqiao Forsythia suspensa anti-allergic activity by lowering IL-4 and IFN-γ mRNA expression [38] antiviral activity [37]
antibacterial activity [37]
anti-inflammatory activity [37]
antioxidant activity [37]
neuroprotective activity [37]
anti-allergic activity [37]
Early Jinyinhua and lianqiao prevent influenza [29] anti-Influenza viral activity [25,26] anti-Influenza viral activity [25,26]
antibacterial, antiviral, antitumor, anti-inflammatory, and antioxidant effects [27]
decrease iNOS, COX-2, NO, prostaglandin E2 (PGE2), TNF-α, IL-1β and IL-6 levels in the lung [28]
Early and intermediate Jingjie Schizonepeta tenuifolia antiviral activity [40] antiviral activity [40]
decrease NF-κB and regulate IFN-γ, IL-4 and IL-2 levels [39]
anti-Influenza viral activity [96]
Early Danzhuye Herba Lophatheri antiviral, antibacterial, antioxidant, anticancer activity and suppression of metastasis [41]
Early Mahuang Ephedra sinica anti-influenza viral activity [44]
anti-influenza viral effects by regulating the TLR7/NF-κB signal pathway [45]
inhibit influenza virus replication and mRNA expression via the TLR4 and TLR7 signaling pathways [46]
anti-inflammatory effects by decreasing the expression of IL-6, MCP-1 and TNF-α, and increasing expression of IL-10 [47]
Early and intermediate Gancao Glycyrrhiza uralensis antiviral activity [50] antiviral activity [95]
SARS-associated viral inhibition [51-53] anti-Influenza viral activity [94]
antibacterial, anti-inflammatory and anticancer effect [49]
suppression of platelet responses in acute respiratory distress syndrome [54]
suppression of Toll-like receptor 4 (TLR-4) in acute lung injury [55]
anti-Influenza virus activity [94]
Early Dahuang Rheum rhabarbarum anti-fibrosis effect [58,59] blocks S protein and ACE2 interaction [61]
anticancer effect [60]
Early Jianghuang Curcumae Longae antibacterial, antiviral, antifungal, anticancer, antioxidant, and anti-inflammatory effects [63,64] antibacterial, antiviral, antifungal, anticancer, antioxidant, and anti-inflammatory effects [63,64]
Early Guanghuoxiang Herba Pogostemonis antiviral activity [65]
Early Zuling Polyporus Sclerotium antiviral activity (hepatitis B) [68] Immunomodulatory activity [66]
Early Zexie Alismatis Rhizoma antiviral activity (hepatitis B) [69]
Early Cangzhu Rhizoma Atractylodis anti-influenza A virus activity via the TLR7 signaling pathway, decreasing IL-6, TNF-α and IL-1β levels, and increasing IFN-β levels [72]
anti-inflammatory effect [70]
gastroprotective effects [71]
Intermediate Daqingye Folium Isatidis antiviral activity [76,78] antiviral activity [76,78]
anti-Influenza viral activity [76,77] anti-Influenza viral activity [75,76]
Intermediate Banlangen Radix Isatidis anti-Influenza viral activity [84] antiviral activity [85-88]
anti-Influenza viral activity [79-84]
Intermediate Zicao Radix Arnebiae antiviral activity [89,90]
Intermediate Mianmaguanzhong Dryopteridis Crassirhizomatis Rhizoma anti-Influenza viral activity [91]
Intermediate Yinchen Artemisiae Scopariae antiviral activity [92,93]
Intermediate Niubangzi Arctii Tosum anti-Influenza viral activity [94] anti-Influenza viral activity [94]
Intermediate Huangqin Radix Scutellariae antiviral activity [112-116] antiviral activity [109,112-115,117-127]
anti-Influenza viral activity [98-104] anti-Influenza virus activity [98,100-102,105-111]
Intermediate Guanghuoxiang Herba Pogostemonis anti-Influenza viral activity [128] anti-Influenza viral activity [128,129]
Intermediate Qinghao Artemisiae Annuae antiviral activity [133-135]
anti-coronavirus activity [132]
Intermediate Fuling Poria antiviral activity [136]
and anti-Influenza viral activity [136]
Intermediate Zhimu Anemarrhenae rhizoma antiviral activity [65,141]
Intermediate Huanglian Rhizoma Coptidis antiviral activity [145] antiviral activity [143-145]
anti-Influenza viral activity [75]
anti-coronavirus activity [142]
Intermediate Zhizi Fructus Gardeniae antiviral activity [151] antiviral activity [150,151]
anti-Influenza viral activity [147-149] anti-Influenza viral activity [75,146-148]
Intermediate and severe Dihuang Radix Rehmanniae antiviral activity [152] antiviral activity [153] and anti-inflammatory activity [163]
Intermediate Mudanpi Cortex Moutan antiviral activity [153,154]
Severe Danshen Salviae Miltiorrhizae attenuates pulmonary fibrosis [163,164]
Severe Niuhuang Calculus Bovis antipyretic effect [175]
relieves acute lung injury [175]
Severe Shigao Gypsum Fibrosum antipyretic effect [176]
Severe Shuiniujiao Cornu Bubali antipyretic activity [165,166]
Severe Jiegeng Radix platycodonis anti-inflammatory and immunomodulatory activities [167]
attenuates airway inflammation [168]
Severe Renshen Rhizoma Ginseng improves influenza vaccination outcomes [170]
Convalescent Maidong Radix Ophiopogonis ameliorates Doxorubicin-Induced Chronic Heart Failure by Inhibiting Oxidative Stress and Inflammatory Response [197] anti-inflammatory activity [198]
antioxidative and cardiovascular protection [199,200]
regulates intestinal flora [199,200]
Convalescent Tianhuafen Radix Trichosanthis neuroprotective effects in subarachnoid hemorrhage [185] antioxidative effect [184]
Convalescent Sangye Folium Mori promotes macrophagic differentiation [186]
activities of immunomodulation, anti-inflammation, antioxidation [201]
Convalescent Baizhu Atractylodis Macrocephalae anti-tumor activity, anti-inflammatory activity, anti-aging activity, antioxidative activity, anti-osteoporotic activity, neuroprotective activity, and immunomodulatory activity [202]

Table 2.

Pharmaceutical mechanisms of Chinese herbal formulas in treating coronavirus, based on study types conducted during different stages of the disease

Stages Formula Abbreviation Clinical trial Animal study In vitro study
Early Yin Qiao San YQS Shorten fever period [23]
Early Ma Xing Gan Shi Tang MXGST inhibited viral entrance via the PI3K/AKT signaling pathway [42]
reduced lung inflammation and inhibited virus replication via the TLR3 signaling pathway [43]
Intermediate Ganlu Xiaodu Dan GXD antiviral activity [97]
Intermediate Haoqin Qingdan Decoction HQD anti-Influenza viral activity [130,131]
Intermediate Qingwen Baidu Decotion QBD anti-inflammatory activity [137]
promoted immune function [138]
prevention and treatment of acute lung injury [139,140]
Severe Qing Ying Tang QYT ameliorate brain tissue edema, attenuate the cytokine increase in brain tissue [161]
Severe Jie Geng Tang JGT anti-inflammatory effects [157]
Severe and convalescent Sheng Mai San SMS Improved exercise tolerance in patients receiving coronary bypass grafting [201] anti-inflammatory effects [169] protected HUVECs from hypoxia/reoxygenation injury, increased cell viability and NO content, decreased LDH leakage, MDA content and ROS generation [178]
preservation of right ventricular dysfunction during chronic intermittent hypoxia in mice [158]
improvement of heart failure by regulating ROS generation and the CaMKII signaling pathway [204]
protection against doxorubicin-induced cardiotoxicity [205]
inhibition of acute lung injury via the TLR4-mTOR-autophagy pathway [179]
protection against drug-induced myocardial injury [206,207]
Severe Shen Fu Tang SFT rescue in septic shock and resuscitation [170] reduce TNF-α expression [171]
improve systemic microcirculation [171]
prolong hypoxia tolerance duration [171]
Severe An Gong Niu Huang Wan AGNHW anti-inflammatory effects [173,174]
Convalescent Sha Shen Mai Dong Tang SSMDT Alleviation of radiation-induced xerostomia in cancer patients [181-183]
Convalescent Shen Ling Bai Zhu San SLBZS influence the gut microbiota, protect the gut barrier and regulate gut cytokines [188-190]

Early-stage febrile disease

Based on TCM theory, early-stage febrile disease is explained as evil-qi invading lung-wei, presenting as fever, chills, headache, mild sweating and thirst. The symptoms match those of a viral infection in the upper airway. In our experience of coronavirus infection, patients presented with three main syndromes including “heat-toxicity invading lung-wei”, “damp-heat obstructing lung-wei” and “superficial cold and interior heat combining with damp” in the early stage of infection.

Syndrome of heat-toxicity invading lung-wei

Patients with heat-toxicity invading lung-wei syndrome manifest classical symptoms such as fever, chills, headache, mild sweating, thirst and thin white tongue fur. Appropriate treatments consist of Yin Qiao San (YQS) and Ma Xing Gan Shi Tang (MXGST). YQS is composed of Jinyinhua (Flos Lonicerae Japonicae), Lianqiao (Fructus Forsythiae), Jingjie (Schizonepeta tenuifolia Briq), Dandouchi (Semen Sojae Praeparatum), Niubangzi (Fructus Arctii Tosum), Bohe (Herba Menthae), Gancao (Radix Et Rhizoma Glycyrrhizae), Jiegeng (Radix platycodonis), Lugen (Phragmitis Rhizoma) and Danzhuye (Herba Lophatheri). MXGST is composed of Mahuang (Herba Ephedrae), Xingren (Semen Armeniacae Amarum), Shigao (Gypsum Fibrosum) and Gancao. Both formulas are famous for clearing heat and resolving toxin, which are the main mechanisms in early coronavirus infection.

YQS has been used to treat early plague and seasonal influenza for thousands of years. Several randomized controlled clinical trials have demonstrated the antipyretic effect of YQS and its components. Wang et al. found that Oseltamivir and MXGST-YQS, alone and in combination, shortened the time to fever resolution in patients with Hemagglutinin Type 1 and Neuraminidase Type 1 (H1N1) influenza virus infection compared to the CHM untreated control group. The study researchers suggested that MXGST-YQS could be an alternative option for H1N1 infection [23]. During the 2009 H1N1 influenza pandemic, Jinhua Qinggan Granule derived from MXGST and YQS was developed for patients with typical wind-heat affecting lung syndrome [24]. Jinyinhua and Lianqiao as a herbal pair were reported to possess antiviral effects (including against influenza A), antibacterial, antitumor, anti-inflammatory, and antioxidant effects [25-27]. Gao et al. reported that the combination of Jinyinhua and Lianqiao exhibited eanti-inflammatory and anti-oxidative effects by reducing inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and thus decreasing the production of nitro oxide (NO) and prostaglandin E2 (PGE2), as well as reducing levels of tumor necrosis factor alpha (TNF-α), Interleukin 1 beta (IL-1β) and IL-6 expression in the lungs [28]. Liu et al. have shown that compounds including Jinyinhua and Lianqiao could prevent influenza A H1N1 infection in a controlled clinical trial [29]. Jinyinhua exhibited antiviral efficacy (including against influenza A), neuraminidase inhibitory activity, antibacterial, anti-inflammatory, and antioxidant effects [28,30-33]. Kim et al. demonstrated that HS-23, a Jinyinhua extract, harmonized the immune system to attenuate septic injury by suppressing Toll-Like receptor 4 (TLR4) signaling and reversed sepsis-induced immunosuppression status by inhibiting lymphocyte apoptosis in a murine model of infection [34,35]. Kao et al. reported protective and immunomodulatory effects of Jinyinghua, with increases in nuclear Sp1 binding activity, expression of IL-10 and reductions of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) binding activities, as well as decreased levels of TNF-α, IL-1β and IL-6 in the lung [36]. Furthermore, Lianqiao, which was the candidate for SARS-CoV-2 treatment, demonstrated antiviral, antibacterial, anti-inflammatory, antioxidative, neuroprotective and anti-allergic activity [37,38]. In TCM, Jingjie is used for expelling wind, accompanied by chills and gastrointestinal symptoms [39]. Jingjie reportedly suppressese NF-κB and regulates levels of Interferon gamma (IFN-γ), IL-4 and IL-2. Chen et al. have demonstrated that Jingjie also has antiviral activities against enterovirus 71 [40]. Danzhuye has exhibited antiviral, anti-bacterial, antioxidative and anticancer activities associated with the suppression of metastasis [41].

MXGST is a common prescription for seasonal flu infection. Scientific research has found that MXGST regulates the phosphatidylinositol 3-kinase and protein kinase B (PI3K/AKT) signaling pathway related to viral entry in influenza virus infection [42]. Chen et al. have demonstrated that a modified MXGST decoction decreases lung inflammation and inhibits viral replication in RSV-infected mice, through the TLR3 signaling pathway [43]. Mahuang (Ephedra sinica) is famous for resolving exterior invasion of the influenza virus [44]. The anti-influenza virus effect reportedly occurs through the regulation of the TLR7/NF-κB signaling pathway [45], by inhibiting influenza virus replication and messenger ribonucleic acid (mRNA) expression through the TLR4 and TLR7 signaling pathways [46]. Mahuang has also shown anti-inflammatory effects by decreasing the expression of IL-6, monocyte chemoattractant protein-1 (MCP-1) and TNF-α, and increasing the expression of IL-10 [47]. Xingren is used in TCM for down-bearing qi and calming panting. Xingren has shown antiasthma activity, inhibiting type 2 helper T cell responses [48]. Antiviral experiments have not yet Xingren. Gancao (Glycyrrhiza uralensis) is a famous TCM herb that is used to resolve a toxin. Glycyrrhizin has shown broad antiviral, antibacterial, anti-inflammatory, anticancer and hepatoprotective effects in many studies [49]. Glycyrrhizin inhibits viruses such as hepatitis B, human immunodeficiency virus (HIV) and SARS-coronavirus [50]. Previous studies have reported that glycyrrhizin is effective for inhibiting replication of the SARS-associated virus [51-53]. In cases of acute respiratory distress syndrome, glycyrrhizin suppressed platelet responses and alleviated lung destruction associated with the inhibition of the TLR-4/NF-κB signaling pathway [54,55].

Syndrome of damp-heat obstructed lung-wei

Patients with damp-heat obstructed lung-wei syndrome manifest typical symptoms such as low-grade fever, headache of heaviness sensation, poor appetite, fatigue and thick slimy tongue fur. We have used San Ren Tang (SRT) and Sheng Jiang San (SJS) to dispel damp-heat. SRT treats triple burner damp heat, which is composed of Xingren, Yiyiren (Coicis semen), Douko (Amomum cardamomum), Huashi (Talcum), Banxia (Rhizoma pinelliae) and Houpo (Magnoliae officinalis). However, SRT has not been subjected to evidence-based study in coronavirus treatment. SJS has a long history in TCM of specialization for plague diseases, and is composed of Dahuang (Rheum rhabarbarum), Jianghuang (Curcumae longae), Chantui (Cicadae periostracum) and Jiangcan (Bombyx batryticatus). Based on TCM theory, Dahuang is mostly used in gastrointestinal symptoms such as constipation and liver-related disease [56,57]. Dahuang has shown antifibrotic effects, inhibiting stellate cell activation by matrix metalloproteinase (MMP) 1 expression [58,59] and anti-hepatocellular carcinoma invasion by inhibiting MMP-2 and -9 activities [60]. The major compound extracted from Dahuang, emodin, blocked the S protein and ACE2 interactions in SARS-coronavirus [61]. Thus, emodin might be a potential effective drug for new SARS-coronavirus [62]. Jianghuang has shown antibacterial, antiviral, antifungal, anticancer, antioxygenic, and anti-inflammatory effects in both in vitro and in vivo studies [63,64]. In addition to SRT and SJS, we sometimes use the combination of Huo Pu Xia Ling Tang (HPXLT) to enhance the effect of damp clearance. The components of HPXLT are Hohsiang (Agastachis herba), Houpo, Banxia, Chifuling (Poria cocos), Zhuling (Polyporus umbellatus), Zexie (Alismatis rhizoma), Xingren, Yiyiren and Douko (Amomum cardamomum). Hohsiang, the principal drug of HPXLT, elevated immunoglobulin titers and reduced morbidity in an animal study, indicating antiviral activity [65]. In recent studies, Zhuling has demonstrated immunomodulatory [66], anticancer [67] and anti-hepatitis B activities [68]. Zexie has been associated with a wide spectrum of pharmacological effects such as diuretic, antiviral, antibacterial, antitumor, anti-inflammatory and immunomodulatory effects [69].

Syndrome of superficial cold and interior heat with damp

Patients with superficial cold and interior heat with damp syndrome manifest symptoms such as fever, sweating, severe thirst and yellowish slimy tongue fur. We prescribe MXGST and SJS to resolve the exterior cold, clear interior heat and transform dampness. For patients with heavy damp, we add Cangzhu (Rhizoma atractylodis) to dry the dampness. Cangzhu has exhibited anti-inflammatory [70] and gastroprotective effects [71]. Furthermore, atractylon, a derivative from cangzhu, has shown significant anti-influenza A virus effects. By regulating the TLR7 signaling pathway, atractylon is capable of reducing risk of virus-induced lung injury by decreasing levels of IL-6, TNF-α and IL-1β expression and increasing IFN-β expression [72].

Intermediate-stage febrile disease

In the intermediate stage of disease, the patient will have repeated high fevers, cough, limb weakness or fatigue, and may have begun to have dyspnea. The time taken to develop from the early stage to the intermediate stage is about 8 days, by which time the patient may already require hospitalization, and the majority will have bilateral lung involvement on imaging [73]. According to TCM theory, the hyperthermic reaction of patients can be divided into four types of syndromes, as follows: “syndrome of dual exterior and interior heat”; “syndrome of retained dampness-heat toxin”; “syndrome of dampness-heat obstructing the Shaoyang”; and “syndrome of intense heat toxin”.

Syndrome of dual exterior and interior heat

The “Syndrome of dual exterior and interior heat” is a heat syndrome involving both exterior and interior, caused either by a heat pathogen entering the interior before the exterior syndrome is resolved, or by superimposition of a new exterior syndrome on a preexisting illness. It usually manifests with fever, an aversion to wind, headache, flushed face, thirst, irritation or even delirium, constipation, dark-colored urine, reddened tongue with dry yellow coating and rapid forceful floating pulse [74]. For patients suffering from this type of syndrome, modified Qing Fei Jie Du Tang (QFJDT) can be used to clear heat and down-bear fire, enrich yin and moisten dryness of lung.

QFJDF is composed of Daqingye (Folium isatidis), Banlangen (Radix isatidis), Zicao (Radix arnebiae), Chonglou (Paridis rhizoma), Yinchen (Artemisiae scopariae), Mianmaguanzhong (Dryopteridis crassirhizomatis rhizoma), Baibu (Stemonae radix), Gancao and Jiegeng. Daqingye, Banlangen, Zicao, Chonglou, and Mianmaguanzhong all have strong heat-clearing and detoxifying effects and are particularly effective for viral infection. Daqingye has antiviral effects in herpes simplex virus type I, influenza A virus (IAV), coxsackievirus B3 (CVB3), respiratory syncytial virus (RSV), and adenovirus type 7 (Ad-7) [75-78]. Banlangen has anti-influenza viral activities in H1N1, H3N2, H6N2 and H9N2 [79-84]. It also has other antiviral activities in cases of pseudorabies virus, hepatitis B virus and porcine reproductive and respiratory syndrome virus [85-88]. Zicao has antiviral activities in adenovirus type 3 and HIV1 [89,90]. Mianmaguanzhong has anti-influenza virus activity in H5N1 [91]. Yinchen, Baibu and Gancao also exhibit detoxifying effects. Yinchen has antiviral activities in hepatitis B virus [92,93]. Gancao has anti-influenza virus activity in H2N2 [94] and antiviral activity in Ebola virus [95]. Finally, Jiegeng is added to diffuse lung qi and expel the pathogen, giving the whole formula the effects of clearing and detoxifying the lung.

The effect of QFJDF formula for dispersing exterior heat is slightly insufficient. CHM of Jingjie (Schizonepeta tenuifolia), Bohe (Mentha canadensis), Niubangzi (Arctii fructus) and other medicines can be added to disperse exterior heat, and increase the efficiency. After mixing these medicines together, the effects of heat-clearing, detoxifying and purging the lung to down-bear the counterflow will be more powerful. Jingjie has shown anti-influenza virus activity in H1N1 [96], while Niubangzi has shown anti-influenza virus activity in H2N2 [94].

Syndrome of retained dampness-heat toxin

The “syndrome of retained dampness-heat toxin” is marked by redness, swelling, ulceration and exudation of the hand, foot, ear, nose, head, face or genital region, or by fever, jaundice, impaired consciousness, eruptions, reddened tongue and a rapid soggy pulse [74]. When facing this syndrome, physicians can choose modified Gan Lu Xiao Du Dan (GLXDD) to resolve dampness, dispel filth, clear heat and detoxify. GLXDD can significantly inhibit the proliferation of coxsackievirus B2, B3 and B4 strains at a concentration of 25 g/L [97]. GLXDD is composed of Huashi, Yinchen, Huangqin (Radix scutellariae), Shichangpu (Acori tatarinowii), Chuanbeimu (Fritillariae cirrhosae), Chuanmutong (Clematidis armandii), Guanghuoxiang (Herba pogostemonis), Shegan (Belamcandae rhizoma), Lianqiao, Bohe and Amomi fructus rotundus.

Huashi, Yinchen, and Huangqin in GLXDD are greatly used. Huashi can drain dampness and clear heat to release summerheat; Yinchen can drain dampness and clear heat to anti-icteric; Huangqin can drain dampness and clear heat to dry dampness. Huangqin has anti-influenza virus activities in H1N1 and H3N2 infections [98-111]. It also has antiviral activities in coxsackievirus B3, respiratory syncytial virus, hepatitis B virus, HIV1, duck hepatitis A virus type 1, Sendai virus, Newcastle disease virus, vesicular stomatitis virus, dengue virus, Enterovirus 71, tick-borne encephalitis virus, and human T cell leukemia virus type I [109,112-127].

The other herbs, including Shichangpu, Doukou, Guanghuoxiang and Bohe, are applied to resolve turbidity and move qi to regulate the spleen. Guanghuoxiang has anti-influenza virus activity in H1N1 infection [128,129]. Shegan, Chuanbeimu can direct lung qi downward and soothe the throat. Chuanmutong can assist Huashi and Yinchen to clear heat and drain dampness. Lianqiao can assist Huangqin to clear heat and detoxify. Lianqiao also has anti-influenza virus activity in H1N1 infection [25]. After being combined together, this formula can resolve dampness to dispel filth, clear heat and detoxify.

Syndrome of dampness-heat obstructing the Shaoyang

When the dampness-heat pathogen obstructs qi movements of Shaoyang, the “syndrome of dampness-heat obstructing the Shaoyang” develops, in which the pathogen products exist between the exterior and interior of the body, marked by clinical manifestations of alternate fever and chills, fullness and choking feelings in the chest and hypochondriac regions, a dry throat and string-like pulses [74]. For this syndrome, the patients can be prescribed a modified Hao Qin Qing Dan Decoction (HQQDD) to purge Shaoyang and separate dampness-heat. HQQDD in combination with ribavirin inhibited the expression of CD14 and TLR4 and prevented influenza virus A1/FM1 from inducing febrile disease dampness-heat syndrome in mice [130]. HQQDD treats the damp-heat syndrome of pneumonia infection of influenza virus by reducing TLR2 expression, decreasing the levels of NF-κB mRNA and the proportionality of Th1/Th2 [131]. HQQDD is composed of Qinghao (Artemisiae annuae), Zhuru (Bambusae caulis), Banxia, Fuling, Huangqin, Zhiqiao, Chenpi (Citri reticulatae), Huashi, Gancao and Qingdai (Indigo naturalis).

Qinghao and Huangqin are bitter-cold, aromatic herbs that expel the pathogen and purge heat in Shaoyang. Both herbs act as sovereign medicines in this formula. Qinghao has demonstrated anti-coronavirus activity in SARS-associated coronavirus [132] and also antiviral activities in hepatitis C virus, HIV1, and bovine viral diarrhea virus [133-135]. In addition, both Zhuru and Banxia can clear and resolve phlegm-heat, while the combination of Chenpi and Zhiqiao can soothe the chest and harmonize the stomach to down-bear counterflow. The four above-mentioned herbs are minister medicines in this formula, while Fuling, Huashi and Qingdai act as assistants. These assistant herbs can clear heat, drain dampness, and guide pathogens to urine. Fuling has anti-Influenza virus activity in H1N1 [136] as well as anti-hepatitis B virus activity [134]. Such compatibility can clear Shaoyang’s pathogenic heat, resolve phlegm-dampness and soothe qi movement.

Syndrome of intense heat toxin

The “Intense heat toxin syndrome” arises when accumulated exuberant pathogenic fire-heat transforms into a toxin and manifests as sores and eruptive diseases, marked by fever, thirst, cough, dyspnea or chest pain, constipation, dark urine, and a reddened tongue with a yellow coating [74]. For this condition, the physician can choose the modified Qing Wen Bai Du Decoction (QWBDD) to clear heat, cool blood, purge fire and detoxify. By changing the level of inflammatory mediators, QWBDD has anti-inflammatory effects in sepsis [137]. It has also shown significant effects in cytoimmunity and humoral immunity, and the potentiation of immune function [138]. Verbascoside and angoroside C in QWBDD play a key role in reducing pulmonary edema. Ethyl gallate, pentagalloylglucose, galloyl paeoniflorin, mudanpioside C and harpagoside in QWBDD can treat lipopolysaccharide-induced acute lung injury, mainly by reducing the infiltration of activated polymorphonuclear leukocytes [139,140]. QWBDD is composed of Shigao, Dihuang (Radix rehmanniae), Huanglian (Rhizoma coptidis), Zhizi (Fructus gardeniae), Jiegeng, Huangqin, Zhimu (Anemarrhenae rhizoma), Chishao (Paeoniae radix Rubra), Xuanshen (Scrophulariae radix), Lianqiao, Danzhuye, Mudanpi (Cortex moutan), and Gancao. This formula consists of three major formulas. It includes mainly Bai Hu Tang (BHT) with a clearing heat toxin in qi aspect, Huang Lien Jie Du Decoction (HLJDD) with a fire purging effect and Xi Jiao Di Huang Decoction (XJDHD) with a blood cooling effect.

QWBDD can treat pestilence and heat toxin both on interior and exterior blazing of both qi and blood. This formula focuses on massively clearing heat toxin in the qi aspect of yang brightness, so it uses a lot of Shigao with Zhimu and Gancao. This idea originates from another formula, Bai Hu Tang (BHT) which can clear heat and engender fluid. Zhimu has antiviral activity in respiratory syncytial virus and Newcastle disease virus infection [65,141].

Huanglian, Huangqin and Zhizi are often used together. This prescription is similar to another formula, Huang Lien Jie Du Decoction (HLJDD), which can purge fire of triple energizers. Huanglian has anti-influenza virus activity [75]. Huanglian has also demonstrated anti-coronavirus activity in the porcine epidemic diarrhea virus [142], and antiviral activity in herpes simplex virus type I, respiratory syncytial virus and hepatitis C virus [143-145]. Zhizi has shown anti-influenza virus activity in H1N1 infection [75,146-149], and demonstrated antiviral activity in Enterovirus 71 and white spot syndrome virus [150,151].

Shuiniujiao (Cornu Bubali), Dihuang, Chishao and Mudanpi in combination is similar to Xi Jiao Di Huang Decoction (XJDHD), which can clear heat, detoxify, cool the blood and dissipate stasis. This prescription effectively treats the syndrome of blazing both qi and blood. Dihuang has demonstrated antiviral activity in duck hepatitis A virus type 1 infection [150]. Mudanpi has also shown antiviral activity in hepatitis B and C viruses [153,154]. Lianqiao and Xuanshen are applied to dissolve floating fire.

In the composition of these four formulas, 18 single herbs have been proven to have antiviral activities, two of which are specifically effective at fighting coronavirus - Qinghao and Huanglian [142].

Severe-stage febrile disease

In the severe stage, the disease is further aggravated if not treated properly. Patients may present with severe dyspnea, hypoxemia, and respiratory failure due to acute lung injury. The heavy load of inflammation may lead to pulmonary fibrosis, which affects lung function in the long-term [155]. In this stage, patients may also present with impaired consciousness due to direct viral invasion of the central nervous system (CNS) or induction of CNS inflammatory mediators [156]. Patients in this stage are at risk of septic shock with multiple organ dysfunction syndrome (MODS) due to a cytokine storm immune response [73].

Syndrome of phlegm and blood stasis obstructing the lung

Based on TCM theory, retention of pathological products such as phlegm and blood stasis can block qi circulation and therefore impair lung function. Qi stagnation resulting from retention of the pathological products may transform into fire, which causes damage to qi and yin. The excessive pathogenic qi may lead to expulsion of the original qi, resulting in abrupt failure of body function. The exuberant heat may disturb the heart spirit and cause impaired consciousness. Qing Ying Tang (QYT) is a classic CHM formula for febrile disease entering the ying level, which presents with night fever, delirium, and insomnia. QYT is composed of Shuiniujiao, Dihuang, Xuanshen, Danzhuye, Maidong (Radix ophiopogonis), Danshen (Salviae miltiorrhizae), Huanglian, Jinyinhua and Jianqiao. Jie Geng Tang (JGT) is composed of Jiegeng and Gancao and is well recognized for its efficacy in clearing heat, relieving toxicity, and diffusing the lung to dispel phlegm [157].

Syndrome of dual deficiency of qi and yin

As excessive heat-toxin leads to deficiency of both qi and yin, Sheng Mai San (SMS) is widely used to tonify qi and nourish yin [158]. SMS is composed of renshen (Radix et Rhizoma Ginseng), maidong and wuweizi (Fructus Schisandrae Chinensis).

Syndrome of internal block and external collapse

Shen Fu Tang (SFT) is a well-known CHM formula used to tonify qi and yang, especially for patients with qi and yang collapse [159]. SFT is composed of Renshen and Fuzi (Aconitum carmichaelii). An Gong Niu Huang Wan (AGNHW) and Zi Xue Dan (ZXD) are famous CHM formulas for clearing heat, opening the orifice of the heart and arousing the spirit [160]. AGNHW is composed of Niuhuang (Calculus bovis), Yujin (Radix curcumae), Huanglian, Huangqin, Zhizi, Shuiniujiao, Xionghuang (Realgar), Shexiang (Moschus), Bingpian (Borneolum syntheticum), Zhusha (Cinnabaris), Zhenzhu (Pulvis pernnlae) and Jinbo (Native gold). ZXD is composed of Shigao, Huashi, Cishi (Magnetitum), Xuanshen, Shengma (Cimicifugae Rhizoma), Shuiniujiao, Lingyangjiao (Cornu saigae Tataricae), Chenxiang (Aquilaria agallocha), Muxiang (Radix aucklandiae), Gancao, Mangxiao (Natrii sulfas), Dingxiang (Flos caryophylli), Zhusha, Shexiang and Jinbo.

Several studies have demonstrated the efficacy of the above-mentioned formulas when administered in acute infectious diseases. For example, QYT does not only ameliorate brain tissue edema but also attenuates cytokine increases in brain tissue [161]. Aqueous extract of prepared Dihuang, an ingredient contained in QYT, has demonstrated anti-inflammatory activity in the CNS by inhibiting IL-1 secretion [162]. Danshen in QYT can attenuate pulmonary fibrosis in mouse models by reducing the inflammatory reaction [163,164]. Shuiniujiao in QYT demonstrates antipyretic activity in infectious hyperthermia by enhancing antioxidation enzyme activities and reducing prostaglandin E2 production [165,166]. JGT exhibits anti-inflammatory effects by suppressing the expression of inflammatory mediators such as NF-κB [167]. Platycodin D in Jiegeng has demonstrated anti-inflammatory and immunomodulatory activities [168]. Jiegeng also attenuates airway inflammation by inhibiting mucus hypersecretion and inflammatory cell infiltration [162]. SMS has demonstrated its ability to reduce systemic inflammatory reactions by inhibiting high-sensitivity C-reactive protein (hs-CRP) and inflammatory cytokine levels [169]. Renshen has also improved influenza vaccination outcomes by modulating cytokines to reduce immunopathology during influenza virus infection [170]. Shenfu injection, an herbal extract originated from SFT, can reduce the expression of TNF-α, improve systemic microcirculation, and prolong the hypoxia tolerance duration [171]. A systematic review has shown that Shenfu injection can also increase mean arterial pressure, normalize heart rate, clear serum lactate, and reduce mortality in patients with septic shock [172]. In animal studies, AGNHW has exhibited antipyretic and anti-inflammatory effects associated with reduced expression of TNF-α [173,174]. Niuhuang in AGNHW has not only demonstrated antipyretic effects but also improvements in oxidative stress injury in rats with acute lung injury [175]. Shigao, an ingredient contained in ZXD, has demonstrated antipyretic effects against LPS-induced pyrexia in rats [176].

The convalescent stage

Severe COVID-19 infection is highly associated with myocardial injuries and cardiac arrhythmia, probably due to dysregulation of the RAS/ACE2 system and a cytokine storm, as evidenced by the release of IL-6 and IL-17 during the infection [177]. Pulmonary fibrosis is more likely to develop in patients after severe clinical conditions, especially in the convalescent stage.

The syndrome of dual qi and yin deficiency

In the convalescent period of a febrile disease, multiple organ injuries need to be repaired, which usually belongs to the phase of dual deficiency of Qi and yin in TCM. We suggest herbal regimens to supplement Qi and nourish Yin and several herbs that can improve the microcirculation. SMS, a CHM formula that has been used for thousands of years for improving Qi and Yin, is designed to treat patients with severe dyspnea, sweating and palpitations. SMS has demonstrated protective effects in many types of heart failure. SMS consists of Renshen, Maidong and Wuweizi. Schisandrin, a major ingredient identified in Wuweizi, has demonstrated the ability to protect human umbilical vein endothelial cells from hypoxia/reoxygenation injury, increases cell viability, nitric oxide (NO) content and decreases lactate dehydrogenase (LDH) leakage, MDA content and reactive oxygen species generation [178]. In addition, SMS has shown that it can preserve right ventricular function during chronic intermittent hypoxia in mice [156] and inhibit particulate matter (PM)-induced acute lung injury via the TLR4-mTOR-autophagy pathway [179]. In a meta-analysis of 27 randomized controlled trials involving 2,045 subjects with chronic cor pulmonale heart failure showed that combined therapy with SMS (injection form) improved heart function more effectively than conventional therapy alone [180]. Thus, SMS is believed to be helpful in the convalescence stage by supplementing QiYin and improving heart and lung function.

Sha Shen Mai Dong Tang (SSMDT) is composed of Beishashen (Radix glehniae), Maidong, Yuzhu (Polygonati odorati), Tianhuafen (Radix trichosanthis), Sangye (Folium mori) and Gancao. SSMDT is also used to nourish Qi and Yin, but is more focused on the fluid-humor depletion of the stomach and lung. Several clinical reports have shown that SSMDT alleviates radiation-induced xerostomia in cancer patients [181-183]. The saponins from Tianhuafen have been proven to be antioxidative [184] and neuroprotective [185]. Sangye, the leaf of Morus alba L. (Moraceae) used in SSMDT, promotes macrophagic differentiation by regulating cytokines such as TNF-α, IL-1β, IL-6, and IL-10 [186].

The syndrome of dual deficiency of the lung-spleen

Gut microbiota plays an important role in human immunity, metabolism and diseases. Alteration of gut microbiota is often observed in patients with infectious diseases [187]. Shen Ling Bai Zhu San (SLBZS) is traditionally used for gastrointestinal diseases, especially functional dyspepsia when characterized as Qi-Yin deficiency of the spleen, in TCM theory. The improvement of symptoms associated with SLBZS treatment has been linked to its modulation of gut microbiota [188-190]. In addition, SLBZS promotes the integrity of the intestinal barrier and reduces levels of intestinal inflammatory cytokines [191]. The concept of Qi-Yin deficiency of the spleen is usually applied during the convalescent period of an infection or other immune disorder, such as inflammatory bowel disease [192].

The syndrome of damage to the lung vessels

Pulmonary fibrosis is another problem in patients recovered from COVID-19. To prevent pulmonary fibrosis, TCM theory recommends the use of CHMs such as Taoren (Semen persicae), Honghua (Flos carthami) and Danshen, which are capable of activating blood circulation and dissipating blood stasis. Single components from CHMs, such as flavonoids, terpenes, or alkaloids, have proven beneficial in pulmonary fibrosis [193]. Safflor yellow is the effective part of the aqueous extract from Honghua. In a study of 70 patients with pulmonary fibrosis, combined treatment with Honghua and methylprednisolone yielded higher FEV1/forced vital capacity (FVC) values than methylprednisolone monotherapy [194]. Tanshinone IIA extracted from Danshen has been shown to protect bleomycin-induced pulmonary fibrosis in mice through the ACE2/ANG (1-7) axis and imuunomodulation [195,196].

Conclusion

Based on the disease progression and stages of coronavirus infection, we propose the application of the corresponding principles of CHM treatment in clinical practice. Especially for cancer patients with worse clinical outcomes, CHMs exert antitumor effects by modulating immune response to ameliorate the risk of coronavirus infection. Evil-qi invading lung-wei presents with symptoms similar to coronavirus infection in the early phase and can be treated with CHM of YQS and MXGST, which possess anti-viral activity and anti-inflammatory effects. Single herbs including Jinyinhua, Lianqiao, Jingjie, Danzhuye, Mahuang, Gancao, Dahuang, Jianghuang, Hohsaing, Zuling, Zexie and Cangzhu can be applied to treat the main syndromes, “heat-toxicity invades lung-wei”, “damp-heat obstructs lung-wei” and “superficial cold and interior heat with damp”. Jinyinhua, Lianqiao, Gancao, Dahuang and Jianghuang have been demonstrated antitumor effects. Additionally, Dahuang was reported inhibitory effect of metastasis. The hyperthermic reaction in the intermediate stage of coronavirus infection can be divided into four syndrome types: “dual exterior and interior heat”; “retained dampness-heat toxin”; “dampness-heat obstructing the Shaoyang”; and “intense heat toxin”. CHMs that are used in this stage have mainly antiviral and anti-inflammatory effects, to prevent the disease from developing into a severe stage. The purpose of TCM treatment in the severe stage of disease is to restore normal lung function and improve consciousness. The principles of treatment for cancer patients in intermediate and severe stage are similar with general population. QYT and JGT are prescribed in the treatment of phlegm and blood stasis obstructing the lung syndrome; SMS of dual deficiency of qi and yin syndrome; SFT, AGNHW and ZXD are administered for internal block and external collapse syndrome. In TCM theory, patients in the convalescent period present mostly with the syndrome of either dual deficiency of qi-yin or of the lung-spleen; however, the syndrome of damage to lung vessels persists throughout the entire disease spectrum. Herbal formulas of SMS, SSMDT, SLBZS and their composition herbs are helpful for patients’ pulmonary and vascular recovery from COVID-19 infection in this period. Baizhu used in convalescent stage had both immunomodulatory activity and antitumor effect. SSMDT was reported alleviating radiation-induced xerostomia in cancer patients. We recommend that combining Chinese and Western medicine in clinical practice will synergize the advantages offered by each system of healthcare, ameliorate the disease progression and hasten cancer patients’ recovery in the most effective way.

Acknowledgements

The authors would like to thank Iona MacDonald of China Medical University for the critical reading and revision of our manuscript. This work was supported by the Ministry of Science and Technology of Taiwan (MOST 108-2320-B-039-022) and funded by China Medical University Hospital (DMR-108-007, DMR-108-009, DMR-108-044 and CRS-108-001) and An-Nan Hospital, China Medical University (ANHRF-108-06 and ANHRF-108-08).

Disclosure of conflict of interest

None.

Abbreviations

ACE2

angiotensin converting enzyme 2

CHM

Chinese herbal medicine

CNS

central nervous system

COVID-19

coronavirus disease 2019

COX-2

cyclooxygenase-2

H1N1

hemagglutinin type 1 and neuraminidase type 1

IFN-γ

interferon gamma

IL

interleukin

iNOS

inducible nitric oxide synthase

LDH

lactate dehydrogenase

MCP-1

monocyte chemoattractant protein-1

MDA

malondialdehyde

MMP

matrix metalloproteinase

MODS Mpro (3-CL protease)

multiple organ dysfunction syndrome main protease, (3 chymotrypsin-like protease)

NF-κB

nuclear factor kappa-light-chain-enhancer of activated B cells

NO

nitric oxide

PGE2

prostaglandin E2

PI3K/AKT

phosphatidylinositol 3-kinase and protein kinase B

RSV

respiratory syncytial virus

RT-qPCR

real-time quantitative polymerase chain reaction

SARS

severe acute respiratory syndrome

SARS-CoV-2

severe acute respiratory syndrome coronavirus 2

TCM

traditional Chinese medicine

TLRTMPRSS2

toll-like receptor transmembrane protease, serine 2

TNF-α

tumor necrosis factor alpha

WHO

World Health Organization

Supporting Information

ajcr0010-2010-f1.pdf (181.9KB, pdf)

References

  • 1.Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8(Suppl 1):S9–14. doi: 10.1046/j.1440-1843.2003.00518.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization. Coronavirus disease (COVID-2019) situation reports. 2020 [Google Scholar]
  • 3.Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. doi: 10.1016/S0140-6736(20)30154-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, Wang Z, Wang FS, Liu L, Zhang Z. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020;26:1320–1323. doi: 10.3201/eid2606.200239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323:1610. doi: 10.1001/jama.2020.3227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Nahid M, Ringel JB, Hoffman KL, Alshak MN, Li HA, Wehmeyer GT, Rajan M, Reshetnyak E, Hupert N, Horn EM, Martinez FJ, Gulick RM, Safford MM. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382:2372–2374. doi: 10.1056/NEJMc2010419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10:102–108. doi: 10.1016/j.jpha.2020.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. 2020 [Google Scholar]
  • 11.Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen KY. Coronaviruses-drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15:327–347. doi: 10.1038/nrd.2015.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–337. doi: 10.1016/S1470-2045(20)30096-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, Xiong Y, Xiong H, Wang C, Chen C, Xiong F, Zhang Y, Peng Y, Ge S, Zhen B, Yu T, Wang L, Wang H, Liu Y, Chen Y, Mei J, Gao X, Li Z, Gan L, He C, Li Z, Shi Y, Qi Y, Yang J, Tenen DG, Chai L, Mucci LA, Santillana M, Cai H. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov. 2020;10:783–791. doi: 10.1158/2159-8290.CD-20-0422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10:589–597. doi: 10.1016/S1470-2045(09)70069-5. [DOI] [PubMed] [Google Scholar]
  • 15.You B, Ravaud A, Canivet A, Ganem G, Giraud P, Guimbaud R, Kaluzinski L, Krakowski I, Mayeur D, Grellety T, Lotz JP. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020;21:619–621. doi: 10.1016/S1470-2045(20)30204-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020:e200980. doi: 10.1001/jamaoncol.2020.0980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644–648. doi: 10.1126/science.1117679. [DOI] [PubMed] [Google Scholar]
  • 18.Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB, Chinnaiyan AM. TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res. 2006;66:3396–3400. doi: 10.1158/0008-5472.CAN-06-0168. [DOI] [PubMed] [Google Scholar]
  • 19.Hanson M. Speaking of epidemics in Chinese medicine disease and the geographic imagination in late imperial China. London: Routledge; 2011. [Google Scholar]
  • 20.International expert meeting on the treatment of SARS by traditional Chinese medicine and the integration of traditional Chinese medicine with Western medicine (2003: Beijing, China); SARS: clinical trials on treatment using a combination of traditional Chinese medicine and Western medicine: report of the WHO international expert meeting to review and analyse clinical reports on combination treatment for SARS; 8-10 October 2003; Beijing, People’s Republic of China. World Health Organization; [Google Scholar]
  • 21.Liu X, Zhang M, He L, Li Y. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS) Cochrane Database Syst Rev. 2012;10:CD004882. doi: 10.1002/14651858.CD004882.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wang Y, Zhang Q, Chen Y, Liang CL, Liu H, Qiu F, Dai Z. Antitumor effects of immunity-enhancing traditional Chinese medicine. Biomed Pharmacother. 2020;121:109570. doi: 10.1016/j.biopha.2019.109570. [DOI] [PubMed] [Google Scholar]
  • 23.Wang C, Cao B, Liu QQ, Zou ZQ, Liang ZA, Gu L, Dong JP, Liang LR, Li XW, Hu K, He XS, Sun YH, An Y, Yang T, Cao ZX, Guo YM, Wen XM, Wang YG, Liu YL, Jiang LD. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med. 2011;155:217–225. doi: 10.7326/0003-4819-155-4-201108160-00005. [DOI] [PubMed] [Google Scholar]
  • 24.Li GQ, Zhao J, Tu ZT, Li JB, Liu QQ, Shi LQ, Miao Q, Yuan HQ, Liu XQ, Long YY, Liu ZG, Zhao T, Li L, Tant QH, He YC, Bian YJ, Hu JQ. Treating influenza patients of wind-heat affecting Fei syndrome by jinhua qinggan granule: a double-blinded randomized control trial. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013;33:1631–5. [PubMed] [Google Scholar]
  • 25.Zhou W, Yin A, Shan J, Wang S, Cai B, Di L. Study on the rationality for antiviral activity of Flos Lonicerae Japonicae-Fructus Forsythiae herb Chito-Oligosaccharide via integral pharmacokinetics. Molecules. 2017;22:654. doi: 10.3390/molecules22040654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Qian W, Kang A, Peng L, Xie T, Ji J, Zhou W, Shan J, Di L. Gas chromatography-mass spectrometry based plasma metabolomics of H1N1-induced inflammation in mice and intervention with Flos Lonicerae Japonica-Fructus Forsythiae herb pair. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1092:122–130. doi: 10.1016/j.jchromb.2018.05.047. [DOI] [PubMed] [Google Scholar]
  • 27.Guo YP, Lin LG, Wang YT. Chemistry and pharmacology of the herb pair Flos Lonicerae japonicae-Forsythiae fructus. Chin Med. 2015;10:16. doi: 10.1186/s13020-015-0044-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gao Y, Fang L, Cai R, Zong C, Chen X, Lu J, Qi Y. Shuang-Huang-Lian exerts anti-inflammatory and anti-oxidative activities in lipopolysaccharide-stimulated murine alveolar macrophages. Phytomedicine. 2014;21:461–469. doi: 10.1016/j.phymed.2013.09.022. [DOI] [PubMed] [Google Scholar]
  • 29.Liu B. Clinical observation on the prevention of influenza A H1N1 with the prevention theory of TCM. Tradit Chin Med Res (Chin) 2010;23:46–47. [Google Scholar]
  • 30.Li HB, Yu Y, Mei YD, Meng ZQ, Wang ZZ, Huang WZ, Xiao W, Yao XS. A new hetero dimeric terpenoid derivative, japonicaside C, from the flower buds of Lonicera japonica. Nat Prod Res. 2017;31:143–148. doi: 10.1080/14786419.2016.1219859. [DOI] [PubMed] [Google Scholar]
  • 31.Zhao H, Lai C, Zhang M, Zhou S, Liu Q, Wang D, Geng Y, Wang X. An improved 2D-HPLC-UF-ESI-TOF/MS approach for enrichment and comprehensive characterization of minor neuraminidase inhibitors from Flos Lonicerae Japonicae. J Pharm Biomed Anal. 2019;175:112758. doi: 10.1016/j.jpba.2019.07.006. [DOI] [PubMed] [Google Scholar]
  • 32.Kashiwada Y, Omichi Y, Kurimoto S, Shibata H, Miyake Y, Kirimoto T, Takaishi Y. Conjugates of a secoiridoid glucoside with a phenolic glucoside from the flower buds of Lonicera japonica Thunb. Phytochemistry. 2013;96:423–429. doi: 10.1016/j.phytochem.2013.09.021. [DOI] [PubMed] [Google Scholar]
  • 33.Yu DQ, Chen RY, Huang LJ, Xie FZ, Ming DS, Zhou K, Li HY, Tong KM. The structure and absolute configuration of Shuangkangsu: a novel natural cyclic peroxide from Lonicera japonica (Thunb.) J Asian Nat Prod Res. 2008;10:851–856. doi: 10.1080/10286020802144677. [DOI] [PubMed] [Google Scholar]
  • 34.Kim SJ, Yoon SJ, Kim YM, Hong SW, Yeon SH, Choe KI, Lee SM. HS-23, Lonicera japonica extract, attenuates septic injury by suppressing toll-like receptor 4 signaling. J Ethnopharmacol. 2014;155:256–266. doi: 10.1016/j.jep.2014.05.021. [DOI] [PubMed] [Google Scholar]
  • 35.Kim SJ, Kim JS, Choi HS, Kim YM, Hong SW, Yeon SH, Kim Y, Lee SM. HS-23, a Lonicera japonica extract, reverses sepsis-induced immunosuppression by inhibiting lymphocyte apoptosis. J Ethnopharmacol. 2015;171:231–239. doi: 10.1016/j.jep.2015.05.049. [DOI] [PubMed] [Google Scholar]
  • 36.Kao ST, Liu CJ, Yeh CC. Protective and immunomodulatory effect of flos Lonicerae japonicae by augmenting IL-10 expression in a murine model of acute lung inflammation. J Ethnopharmacol. 2015;168:108–115. doi: 10.1016/j.jep.2015.03.012. [DOI] [PubMed] [Google Scholar]
  • 37.Wang Z, Xia Q, Liu X, Liu W, Huang W, Mei X, Luo J, Shan M, Lin R, Zou D, Ma Z. Phytochemistry, pharmacology, quality control and future research of Forsythia suspensa (Thunb.) Vahl: a review. J Ethnopharmacol. 2018;210:318–339. doi: 10.1016/j.jep.2017.08.040. [DOI] [PubMed] [Google Scholar]
  • 38.Sung YY, Lee AY, Kim HK. Forsythia suspensa fruit extracts and the constituent matairesinol confer anti-allergic effects in an allergic dermatitis mouse model. J Ethnopharmacol. 2016;187:49–56. doi: 10.1016/j.jep.2016.04.015. [DOI] [PubMed] [Google Scholar]
  • 39.Kang H, Moon JY, Sohn NW. Regulation of interferon-gamma, interleukin-4 and interleukin-2 by Schizonepeta tenuifolia through differential effects on nuclear factor-kappaB, NFATc2 and STAT4/6. Exp Biol Med (Maywood) 2010;235:230–236. doi: 10.1258/ebm.2009.008357. [DOI] [PubMed] [Google Scholar]
  • 40.Chen SG, Cheng ML, Chen KH, Horng JT, Liu CC, Wang SM, Sakurai H, Leu YL, Wang SD, Ho HY. Antiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo. Sci Rep. 2017;7:935. doi: 10.1038/s41598-017-01110-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kim A, Im M, Gu MJ, Ma JY. Ethanol extract of Lophatheri Herba exhibits anti-cancer activity in human cancer cells by suppression of metastatic and angiogenic potential. Sci Rep. 2016;6:36277. doi: 10.1038/srep36277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hsieh CF, Lo CW, Liu CH, Lin S, Yen HR, Lin TY, Horng JT. Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus. J Ethnopharmacol. 2012;143:57–67. doi: 10.1016/j.jep.2012.05.061. [DOI] [PubMed] [Google Scholar]
  • 43.Chen ZG, Luo H, Wang SC, Xu JY, Li JX. Antiviral effects of Jinxin oral liquid against respiratory syncytial virus infection in the BALB/c mice model. J Ethnopharmacol. 2015;162:287–295. doi: 10.1016/j.jep.2015.01.002. [DOI] [PubMed] [Google Scholar]
  • 44.Mantani N, Andoh T, Kawamata H, Terasawa K, Ochiai H. Inhibitory effect of Ephedrae herba, an oriental traditional medicine, on the growth of influenza A/PR/8 virus in MDCK cells. Antiviral Res. 1999;44:193–200. doi: 10.1016/s0166-3542(99)00067-4. [DOI] [PubMed] [Google Scholar]
  • 45.Fu YJ, Yan YQ, Qin HQ, Wu S, Shi SS, Zheng X, Wang PC, Chen XY, Tang XL, Jiang ZY. Effects of different principles of Traditional Chinese Medicine treatment on TLR7/NF-κB signaling pathway in influenza virus infected mice. Chin Med. 2018;13:42. doi: 10.1186/s13020-018-0199-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wei WY, Wan HT, Yu L, Lu YY, He Y. Effect and mechanism of Mahuang Tang against influenza A/H1N1 virus in vitro. China Journal of Chinese Materia Medica (Chin) 2018;43:563–570. doi: 10.19540/j.cnki.cjcmm.20171113.010. [DOI] [PubMed] [Google Scholar]
  • 47.Rong R, Li RR, Hou YB, Li J, Ding JX, Zhang CB, Yang Y. Mahuang-Xixin-Fuzi decoction reduces the infection of influenza A virus in Kidney-Yang deficiency syndrome mice. J Ethnopharmacol. 2016;192:217–224. doi: 10.1016/j.jep.2016.07.017. [DOI] [PubMed] [Google Scholar]
  • 48.Do JS, Hwang JK, Seo HJ, Woo WH, Nam SY. Antiasthmatic activity and selective inhibition of type 2 helper T cell response by aqueous extract of semen armeniacae amarum. Immunopharmacol Immunotoxicol. 2006;28:213–225. doi: 10.1080/08923970600815253. [DOI] [PubMed] [Google Scholar]
  • 49.Wang L, Yang R, Yuan B, Liu Y, Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm Sin B. 2015;5:310–315. doi: 10.1016/j.apsb.2015.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Sun ZG, Zhao TT, Lu N, Yang YA, Zhu HL. Research progress of glycyrrhizic acid on antiviral activity. Mini Rev Med Chem. 2019;19:826–832. doi: 10.2174/1389557519666190119111125. [DOI] [PubMed] [Google Scholar]
  • 51.Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045–2046. doi: 10.1016/S0140-6736(03)13615-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hoever G, Baltina L, Michaelis M, Kondratenko R, Baltina L, Tolstikov GA, Doerr HW, Cinatl J Jr. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem. 2005;48:1256–1259. doi: 10.1021/jm0493008. [DOI] [PubMed] [Google Scholar]
  • 53.Li Y, Li J, Fang C. Inhibitory effects of anti-SARS traditional Chinese medicines on the UV irradiation of lambda-lysogen. Am J Chin Med. 2006;34:147–155. doi: 10.1142/S0192415X06003710. [DOI] [PubMed] [Google Scholar]
  • 54.Yu Z, Ohtaki Y, Kai K, Sasano T, Shimauchi H, Yokochi T, Takada H, Sugawara S, Kumagai K, Endo Y. Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome. Int Immunopharmacol. 2005;5:571–580. doi: 10.1016/j.intimp.2004.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lee SA, Lee SH, Kim JY, Lee WS. Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model. J Thorac Dis. 2019;11:1287–1302. doi: 10.21037/jtd.2019.04.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Dong S, Ding Z, Zhang H, Chen Q. Identification of prognostic biomarkers and drugs targeting them in colon adenocarcinoma: a bioinformatic analysis. Integr Cancer Ther. 2019;18:1534735419864434. doi: 10.1177/1534735419864434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Lee JC, Tseng CK, Wu SF, Chang FR, Chiu CC, Wu YC. San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression. J Viral Hepat. 2011;18:e315–324. doi: 10.1111/j.1365-2893.2010.01424.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Jin H, Sakaida I, Tsuchiya M, Okita K. Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Life Sci. 2005;76:2805–2816. doi: 10.1016/j.lfs.2004.09.041. [DOI] [PubMed] [Google Scholar]
  • 59.Pan ZH, Xie Y, He HW. Effects of dahuang zhechong pill on expression and activity of matrix metalloproteinase in rats’ hepatic stellate cells. Chin J Integrated Traditional Western Med (Chin) 2005;25:1100–1103. [PubMed] [Google Scholar]
  • 60.Ha KT, Kim JK, Lee YC, Kim CH. Inhibitory effect of Daesungki-Tang on the invasiveness potential of hepatocellular carcinoma through inhibition of matrix metalloproteinase-2 and -9 activities. Toxicol Appl Pharmacol. 2004;200:1–6. doi: 10.1016/j.taap.2004.03.012. [DOI] [PubMed] [Google Scholar]
  • 61.Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2007;74:92–101. doi: 10.1016/j.antiviral.2006.04.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Ma J, Huo XQ, Chen X, Zhu WX, Yao MC, Qiao YJ, Zhang YL. Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP. China Journal of Chinese Materia Medica (Chin) 2020;45:1219–1224. doi: 10.19540/j.cnki.cjcmm.20200216.401. [DOI] [PubMed] [Google Scholar]
  • 63.Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12:332–347. doi: 10.2174/138945011794815356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014;2014:186864. doi: 10.1155/2014/186864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Wang M, Yu Y, Brad K, Xie W, Zhang XY. The screening and evaluation of herbs and identification of herbal combinations with anti-viral effects on Newcastle disease virus. Br Poult Sci. 2016;57:34–43. doi: 10.1080/00071668.2015.1119245. [DOI] [PubMed] [Google Scholar]
  • 66.Zhang J. A study on the role of immunosuppression in the pathogenesis of brucellosis. Acta Academiae Medicinae Sinicae (Chin) 1992;14:168–172. [PubMed] [Google Scholar]
  • 67.Liu CP, Zhang X, Tan QL, Xu WX, Zhou CY, Luo M, Li X, Huang RY, Zeng X. NF-κB pathways are involved in M1 polarization of RAW 264.7 macrophage by polyporus polysaccharide in the tumor microenvironment. PLoS One. 2017;12:e0188317. doi: 10.1371/journal.pone.0188317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Guo Z, Zang Y, Zhang L. The efficacy of Polyporus umbellatus polysaccharide in treating hepatitis B in China. Prog Mol Biol Transl Sci. 2019;163:329–360. doi: 10.1016/bs.pmbts.2019.03.012. [DOI] [PubMed] [Google Scholar]
  • 69.Zhang LL, Xu W, Xu YL, Chen X, Huang M, Lu JJ. Therapeutic potential of Rhizoma Alismatis: a review on ethnomedicinal application, phytochemistry, pharmacology, and toxicology. Ann N Y Acad Sci. 2017;1401:90–101. doi: 10.1111/nyas.13381. [DOI] [PubMed] [Google Scholar]
  • 70.Bae S, Jung Y, Choi YM, Li S. Effects of er-miao-san extracts on TNF-alpha-induced MMP-1 expression in human dermal fibroblasts. Biol Res. 2015;48:8. doi: 10.1186/0717-6287-48-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Yu Y, Jia TZ, Cai Q, Jiang N, Ma MY, Min DY, Yuan Y. Comparison of the anti-ulcer activity between the crude and bran-processed Atractylodes lancea in the rat model of gastric ulcer induced by acetic acid. J Ethnopharmacol. 2015;160:211–218. doi: 10.1016/j.jep.2014.10.066. [DOI] [PubMed] [Google Scholar]
  • 72.Cheng Y, Mai JY, Hou TL, Ping J, Chen JJ. Antiviral activities of atractylon from Atractylodis Rhizoma. Mol Med Rep. 2016;14:3704–3710. doi: 10.3892/mmr.2016.5713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.World Health Organization. Regional office for the Western P. WHO international standard terminologies on traditional medicine in the Western pacific region. Manila: WHO Regional Office for the Western Pacific; 2007. [Google Scholar]
  • 75.Han X, Zhang DK, Guo YM, Feng WW, Dong Q, Zhang CE, Zhou YF, Liu Y, Wang JB, Zhao YL, Xiao XH, Yang M. Screening and evaluation of commonly-used anti-influenza Chinese herbal medicines based on anti-neuraminidase activity. Chin J Nat Med. 2016;14:794–800. doi: 10.1016/S1875-5364(16)30095-4. [DOI] [PubMed] [Google Scholar]
  • 76.Deng YP, Liu YY, Liu Z, Li J, Zhao LM, Xiao H, Ding XH, Yang ZQ. Antiviral activity of Folium isatidis derived extracts in vitro and in vivo. Am J Chin Med. 2013;41:957–969. doi: 10.1142/S0192415X1350064X. [DOI] [PubMed] [Google Scholar]
  • 77.Liu Z, Yang ZQ, Xiao H. Antiviral activity of the effective monomers from Folium Isatidis against influenza virus in vivo. Virol Sin. 2010;25:445–451. doi: 10.1007/s12250-010-3142-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Fang JG, Hu Y, Tang J, Wang WQ, Yang ZQ. Antiviral effect of Folium Isatidis on herpes simplex virus type I. Zhongguo Zhong Yao Za Zhi. 2005;30:1343–6. [PubMed] [Google Scholar]
  • 79.Xiao P, Ye W, Chen J, Li X. Antiviral activities against influenza virus (FM1) of bioactive fractions and representative compounds extracted from Banlangen (Radix Isatidis) J Tradit Chin Med (Chin) 2016;36:369–376. doi: 10.1016/S0254-6272(16)30051-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Li Z, Li L, Zhou H, Zeng L, Chen T, Chen Q, Zhou B, Wang Y, Chen Q, Hu P, Yang Z. Radix isatidis polysaccharides inhibit influenza a virus and influenza A virus-induced inflammation via suppression of host tlr3 signaling in vitro. Molecules. 2017;22:116. doi: 10.3390/molecules22010116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Nie LX, Wu YL, Dai Z, Ma SC. Antiviral activity of Isatidis Radix derived glucosinolate isomers and their breakdown products against influenza A in vitro/ovo and mechanism of action. J Ethnopharmacol. 2020;251:112550. doi: 10.1016/j.jep.2020.112550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Ke L, Wen T, Bradshaw JP, Zhou J, Rao P. Antiviral decoction of Isatidis Radix (ban lan gen) inhibited influenza virus adsorption on MDCK cells by cytoprotective activity. J Tradit Complement Med. 2012;2:47–51. doi: 10.1016/S2225-4110(16)30070-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Ma LN, Zhang CE, Yan D, Tan MR, Li HB, Zhang LL, Xiong Y, Xiao XH. Screening bioactive compounds inhibiting influenza virus from isatidis radix by ultrafiltration mass spectrometry. Zhongguo Zhong Yao Za Zhi. 2014;39:812–6. [PubMed] [Google Scholar]
  • 84.Liang X, Huang Y, Pan X, Hao Y, Chen X, Jiang H, Li J, Zhou B, Yang Z. Erucic acid from Isatis indigotica Fort. Suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-kappaB and p38 MAPK pathway. J Pharm Anal. 2020;10:130–146. doi: 10.1016/j.jpha.2019.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.He LW, Liu HQ, Chen YQ, Yang JY, Wang TL, Li W. Total synthesis and anti-viral activities of an extract of Radix isatidis. Molecules. 2014;19:20906–20912. doi: 10.3390/molecules191220906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Tong C, Chen Z, Liu F, Qiao Y, Chen T, Wang X. Antiviral activities of Radix isatidis polysaccharide against pseudorabies virus in swine testicle cells. BMC Complement Med Ther. 2020;20:48. doi: 10.1186/s12906-020-2838-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Wang T, Wang X, Zhuo Y, Si C, Yang L, Meng L, Zhu B. Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway. J Ethnopharmacol. 2020;257:112782. doi: 10.1016/j.jep.2020.112782. [DOI] [PubMed] [Google Scholar]
  • 88.Wei ZY, Wang XB, Zhang HY, Yang CH, Wang YB, Xu DH, Chen HY, Cui BA. Inhibitory effects of indigowoad root polysaccharides on porcine reproductive and respiratory syndrome virus replication in vitro. Antivir Ther. 2011;16:357–363. doi: 10.3851/IMP1755. [DOI] [PubMed] [Google Scholar]
  • 89.Gao H, Liu L, Qu ZY, Wei FX, Wang SQ, Chen G, Qin L, Jiang FY, Wang YC, Shang L, Gao CY. Anti-adenovirus activities of shikonin, a component of Chinese herbal medicine in vitro. Biol Pharm Bull. 2011;34:197–202. doi: 10.1248/bpb.34.197. [DOI] [PubMed] [Google Scholar]
  • 90.Chen X, Yang L, Zhang N, Turpin JA, Buckheit RW, Osterling C, Oppenheim JJ, Howard OM. Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2003;47:2810–2816. doi: 10.1128/AAC.47.9.2810-2816.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Ou C, Zhang Q, Wu G, Shi N, He C. Dryocrassin ABBA, a novel active substance for use against amantadine-resistant H5N1 avian influenza virus. Front Microbiol. 2015;6:592. doi: 10.3389/fmicb.2015.00592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Geng CA, Yang TH, Huang XY, Yang J, Ma YB, Li TZ, Zhang XM, Chen JJ. Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes. J Ethnopharmacol. 2018;224:283–289. doi: 10.1016/j.jep.2018.06.005. [DOI] [PubMed] [Google Scholar]
  • 93.Geng CA, Huang XY, Chen XL, Ma YB, Rong GQ, Zhao Y, Zhang XM, Chen JJ. Three new anti-HBV active constituents from the traditional Chinese herb of Yin-Chen (Artemisia scoparia) J Ethnopharmacol. 2015;176:109–117. doi: 10.1016/j.jep.2015.10.032. [DOI] [PubMed] [Google Scholar]
  • 94.Kobayashi M, Davis SM, Utsunomiya T, Pollard RB, Suzuki F. Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza A2 virus infection in mice. Am J Chin Med. 1999;27:53–62. doi: 10.1142/S0192415X99000082. [DOI] [PubMed] [Google Scholar]
  • 95.Fu X, Wang Z, Li L, Dong S, Li Z, Jiang Z, Wang Y, Shui W. Novel chemical ligands to ebola virus and marburg virus nucleoproteins identified by combining affinity mass spectrometry and metabolomics approaches. Sci Rep. 2016;6:29680. doi: 10.1038/srep29680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.He T, Tang Q, Zeng N, Gou L, Liu JW, Yang J, Yu L, Wang Z, Gong XP. Study on effect and mechanism of volatile oil of schizonepetae herba and its essential components against influenza virus. Zhongguo Zhong Yao Za Zhi. 2013;38:1772–7. [PubMed] [Google Scholar]
  • 97.He Y, Wu C, Zhao G. Experimental study on inhibitory effect of ganlu xiaodu Dan on coxackie virus in vitro. Chin J Integrated Traditional Western Med (Chin) 1998;18:737–740. [PubMed] [Google Scholar]
  • 98.Zhang Y, Lyu C, Fong SYK, Wang Q, Li C, Ho NJ, Chan KS, Yan X, Zuo Z. Evaluation of potential herb-drug interactions between oseltamivir and commonly used anti-influenza Chinese medicinal herbs. J Ethnopharmacol. 2019;243:112097. doi: 10.1016/j.jep.2019.112097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Zhi HJ, Zhu HY, Zhang YY, Lu Y, Li H, Chen DF. In vivo effect of quantified flavonoids-enriched extract of Scutellaria baicalensis root on acute lung injury induced by influenza a virus. Phytomedicine. 2019;57:105–116. doi: 10.1016/j.phymed.2018.12.009. [DOI] [PubMed] [Google Scholar]
  • 100.Ding Y, Dou J, Teng Z, Yu J, Wang T, Lu N, Wang H, Zhou C. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase. Arch Virol. 2014;159:3269–3278. doi: 10.1007/s00705-014-2192-2. [DOI] [PubMed] [Google Scholar]
  • 101.Chu M, Xu L, Zhang MB, Chu ZY, Wang YD. Role of Baicalin in anti-influenza virus A as a potent inducer of IFN-Gamma. Biomed Res Int. 2015;2015:263630. doi: 10.1155/2015/263630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Chen L, Dou J, Su Z, Zhou H, Wang H, Zhou W, Guo Q, Zhou C. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res. 2011;91:314–320. doi: 10.1016/j.antiviral.2011.07.008. [DOI] [PubMed] [Google Scholar]
  • 103.Xu G, Dou J, Zhang L, Guo Q, Zhou C. Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biol Pharm Bull. 2010;33:238–243. doi: 10.1248/bpb.33.238. [DOI] [PubMed] [Google Scholar]
  • 104.Nagai T, Miyaichi Y, Tomimori T, Suzuki Y, Yamada H. In vivo anti-influenza virus activity of plant flavonoids possessing inhibitory activity for influenza virus sialidase. Antiviral Res. 1992;19:207–217. doi: 10.1016/0166-3542(92)90080-o. [DOI] [PubMed] [Google Scholar]
  • 105.Ji S, Li R, Wang Q, Miao WJ, Li ZW, Si LL, Qiao X, Yu SW, Zhou DM, Ye M. Anti-H1N1 virus, cytotoxic and Nrf2 activation activities of chemical constituents from Scutellaria baicalensis. J Ethnopharmacol. 2015;176:475–484. doi: 10.1016/j.jep.2015.11.018. [DOI] [PubMed] [Google Scholar]
  • 106.Chung ST, Chien PY, Huang WH, Yao CW, Lee AR. Synthesis and anti-influenza activities of novel baicalein analogs. Chem Pharm Bull (Tokyo) 2014;62:415–421. doi: 10.1248/cpb.c13-00897. [DOI] [PubMed] [Google Scholar]
  • 107.Seong RK, Kim JA, Shin OS. Wogonin, a flavonoid isolated from Scutellaria baicalensis, has anti-viral activities against influenza infection via modulation of AMPK pathways. Acta Virol. 2018;62:78–85. doi: 10.4149/av_2018_109. [DOI] [PubMed] [Google Scholar]
  • 108.Hour MJ, Huang SH, Chang CY, Lin YK, Wang CY, Chang YS, Lin CW. Baicalein, ethyl acetate, and chloroform extracts of Scutellaria baicalensis inhibit the neuraminidase activity of pandemic 2009 H1N1 and seasonal influenza A viruses. Evid Based Complement Alternat Med. 2013;2013:750803. doi: 10.1155/2013/750803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Leonova GN, Shutikova AL, Lubova VA, Maistrovskaya OS. Inhibitory activity of Scutellaria baicalensis flavonoids against Tick-Borne encephalitis virus. Bull Exp Biol Med. 2020;168:665–668. doi: 10.1007/s10517-020-04776-y. [DOI] [PubMed] [Google Scholar]
  • 110.Nagai T, Moriguchi R, Suzuki Y, Tomimori T, Yamada H. Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4’-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis. Antiviral Res. 1995;26:11–25. doi: 10.1016/0166-3542(94)00062-d. [DOI] [PubMed] [Google Scholar]
  • 111.Nagai T, Suzuki Y, Tomimori T, Yamada H. Antiviral activity of plant flavonoid, 5,7,4’-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis against influenza A (H3N2) and B viruses. Biol Pharm Bull. 1995;18:295–299. doi: 10.1248/bpb.18.295. [DOI] [PubMed] [Google Scholar]
  • 112.Fu Q, Gao L, Fu X, Meng Q, Lu Z. Scutellaria baicalensis inhibits coxsackievirus B3-induced myocarditis via AKT and p38 pathways. J Microbiol Biotechnol. 2019;29:1230–1239. doi: 10.4014/jmb.1904.04050. [DOI] [PubMed] [Google Scholar]
  • 113.Shi H, Ren K, Lv B, Zhang W, Zhao Y, Tan RX, Li E. Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice. Sci Rep. 2016;6:35851. doi: 10.1038/srep35851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Kwon BE, Song JH, Song HH, Kang JW, Hwang SN, Rhee KJ, Shim A, Hong EH, Kim YJ, Jeon SM, Chang SY, Kim DE, Cho S, Ko HJ. Antiviral activity of Oroxylin A against Coxsackievirus B3 alleviates virus-induced acute pancreatic damage in mice. PLoS One. 2016;11:e0155784. doi: 10.1371/journal.pone.0155784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Chen Y, Yao F, Ming K, Shi J, Zeng L, Wang D, Wu Y, Hu Y, Liu J. Assessment of the effect of Baicalin on duck virus hepatitis. Curr Mol Med. 2019;19:376–386. doi: 10.2174/1566524019666190405095301. [DOI] [PubMed] [Google Scholar]
  • 116.Dou J, Chen L, Xu G, Zhang L, Zhou H, Wang H, Su Z, Ke M, Guo Q, Zhou C. Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase. Arch Virol. 2011;156:793–801. doi: 10.1007/s00705-011-0917-z. [DOI] [PubMed] [Google Scholar]
  • 117.Jia Y, Xu R, Hu Y, Zhu T, Ma T, Wu H, Hu L. Anti-NDV activity of baicalin from a traditional Chinese medicine in vitro. J Vet Med Sci. 2016;78:819–824. doi: 10.1292/jvms.15-0572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Blach-Olszewska Z, Jatczak B, Rak A, Lorenc M, Gulanowski B, Drobna A, Lamer-Zarawska E. Production of cytokines and stimulation of resistance to viral infection in human leukocytes by Scutellaria baicalensis flavones. J Interferon Cytokine Res. 2008;28:571–581. doi: 10.1089/jir.2008.0125. [DOI] [PubMed] [Google Scholar]
  • 119.Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S. Novel antiviral activity of baicalein against dengue virus. BMC Complement Altern Med. 2012;12:214. doi: 10.1186/1472-6882-12-214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Tseng YP, Wu YC, Leu YL, Yeh SF, Chou CK. Scutellariae radix suppresses hepatitis B virus production in human hepatoma cells. Front Biosci (Elite Ed) 2010;2:1538–1547. doi: 10.2741/e213. [DOI] [PubMed] [Google Scholar]
  • 121.Zandi K, Lim TH, Rahim NA, Shu MH, Teoh BT, Sam SS, Danlami MB, Tan KK, Abubakar S. Extract of scutellaria baicalensis inhibits dengue virus replication. BMC Complement Altern Med. 2013;13:91. doi: 10.1186/1472-6882-13-91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Moghaddam E, Teoh BT, Sam SS, Lani R, Hassandarvish P, Chik Z, Yueh A, Abubakar S, Zandi K. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci Rep. 2014;4:5452. doi: 10.1038/srep05452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Choi HJ, Song HH, Lee JS, Ko HJ, Song JH. Inhibitory effects of norwogonin, Oroxylin A, and mosloflavone on enterovirus 71. Biomol Ther (Seoul) 2016;24:552–558. doi: 10.4062/biomolther.2015.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Ma SC, Du J, But PP, Deng XL, Zhang YW, Ooi VE, Xu HX, Lee SH, Lee SF. Antiviral Chinese medicinal herbs against respiratory syncytial virus. J Ethnopharmacol. 2002;79:205–211. doi: 10.1016/s0378-8741(01)00389-0. [DOI] [PubMed] [Google Scholar]
  • 125.Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW, Wang JM. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun. 2000;276:534–538. doi: 10.1006/bbrc.2000.3485. [DOI] [PubMed] [Google Scholar]
  • 126.Li BQ, Fu T, Yan YD, Baylor NW, Ruscetti FW, Kung HF. Inhibition of HIV infection by baicalin-a flavonoid compound purified from Chinese herbal medicine. Cell Mol Biol Res. 1993;39:119–124. [PubMed] [Google Scholar]
  • 127.Baylor NW, Fu T, Yan YD, Ruscetti FW. Inhibition of human T cell leukemia virus by the plant flavonoid baicalin (7-glucuronic acid, 5,6-dihydroxyflavone) J Infect Dis. 1992;165:433–437. doi: 10.1093/infdis/165.3.433. [DOI] [PubMed] [Google Scholar]
  • 128.Yu Y, Zhang Y, Wang S, Liu W, Hao C, Wang W. Inhibition effects of patchouli alcohol against influenza a virus through targeting cellular PI3K/Akt and ERK/MAPK signaling pathways. Virol J. 2019;16:163. doi: 10.1186/s12985-019-1266-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Wu XL, Ju DH, Chen J, Yu B, Liu KL, He JX, Dai CQ, Wu S, Chang Z, Wang YP, Chen XY. Immunologic mechanism of Patchouli alcohol anti-H1N1 influenza virus may through regulation of the RLH signal pathway in vitro. Curr Microbiol. 2013;67:431–436. doi: 10.1007/s00284-013-0381-y. [DOI] [PubMed] [Google Scholar]
  • 130.Luo HH, Zhang FX, Wu W, Wang XH. Haoqin Qingdan Decoction and ribavirin therapy downregulate CD14 and toll-like receptor 4 in febrile disease with dampness-heat syndrome in a mouse model. Chin J Integr Med. 2016;22:768–773. doi: 10.1007/s11655-016-2097-2. [DOI] [PubMed] [Google Scholar]
  • 131.Pan Y, Luo BD, Lin PZ, Liu Y, Wan WR, Guo JQ. The mechanism of signal extension in Haoqin Qingdan decoction immunity activity in Damp-heat syndrome of pneumonia disease infected by influenza virus. Chin J Prev Med (Chin) 2010;44:612–616. [PubMed] [Google Scholar]
  • 132.Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005;67:18–23. doi: 10.1016/j.antiviral.2005.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Romero MR, Serrano MA, Vallejo M, Efferth T, Alvarez M, Marin JJ. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV) Planta Med. 2006;72:1169–1174. doi: 10.1055/s-2006-947198. [DOI] [PubMed] [Google Scholar]
  • 134.Blazquez AG, Fernandez-Dolon M, Sanchez-Vicente L, Maestre AD, Gomez-San Miguel AB, Alvarez M, Serrano MA, Jansen H, Efferth T, Marin JJ, Romero MR. Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis. Bioorg Med Chem. 2013;21:4432–4441. doi: 10.1016/j.bmc.2013.04.059. [DOI] [PubMed] [Google Scholar]
  • 135.Lubbe A, Seibert I, Klimkait T, van der Kooy F. Ethnopharmacology in overdrive: the remarkable anti-HIV activity of Artemisia annua. J Ethnopharmacol. 2012;141:854–859. doi: 10.1016/j.jep.2012.03.024. [DOI] [PubMed] [Google Scholar]
  • 136.Wu Y, Li S, Li H, Zhao C, Ma H, Zhao X, Wu J, Liu K, Shan J, Wang Y. Effect of a polysaccharide from Poria cocos on humoral response in mice immunized by H1N1 influenza and HBsAg vaccines. Int J Biol Macromol. 2016;91:248–257. doi: 10.1016/j.ijbiomac.2016.05.046. [DOI] [PubMed] [Google Scholar]
  • 137.Yu ZM, Liu ZH, Chen J, Zeng Q. Anti-inflammatory effect of Qingwen Baidu Decoction in sepsis rats. Chin J Integr Med. 2014;20:934–943. doi: 10.1007/s11655-014-1863-x. [DOI] [PubMed] [Google Scholar]
  • 138.Guo S, Fu S, Xu Q, Zhang Z, Wang Y, Shen Z. Immune function of Chinese formula Qingwen Baidu granule in broilers. Cent Eur J Immunol. 2015;40:149–152. doi: 10.5114/ceji.2015.52827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Zhang Q, Nie J, Chen SJ, Li Q. Protective effects of ethyl gallate and pentagalloylglucose, the active components of Qingwen Baidu Decoction, against lipopolysaccharide-induced acute lung injury in rats. Drug Des Devel Ther. 2019;13:71–77. doi: 10.2147/DDDT.S186029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Zhang Q, Lei HM, Wang PL, Ma ZQ, Zhang Y, Wu JJ, Nie J, Chen SJ, Han WJ, Wang Q, Chen DY, Cai CK, Li Q. Bioactive components from Qingwen Baidu Decoction against LPS-induced acute lung injury in rats. Molecules. 2017;22:692. doi: 10.3390/molecules22050692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Bae G, Yu JR, Lee J, Chang J, Seo EK. Identification of nyasol and structurally related compounds as the active principles from Anemarrhena asphodeloides against respiratory syncytial virus (RSV) Chem Biodivers. 2007;4:2231–2235. doi: 10.1002/cbdv.200790181. [DOI] [PubMed] [Google Scholar]
  • 142.Kim HY, Shin HS, Park H, Kim YC, Yun YG, Park S, Shin HJ, Kim K. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex. J Clin Virol. 2008;41:122–128. doi: 10.1016/j.jcv.2007.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Hung TC, Jassey A, Lin CJ, Liu CH, Lin CC, Yen MH, Lin LT. Methanolic extract of Rhizoma Coptidis inhibits the early viral entry steps of hepatitis C virus infection. Viruses. 2018;10:669. doi: 10.3390/v10120669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Chin LW, Cheng YW, Lin SS, Lai YY, Lin LY, Chou MY, Chou MC, Yang CC. Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol. 2010;155:1933–1941. doi: 10.1007/s00705-010-0779-9. [DOI] [PubMed] [Google Scholar]
  • 145.Lee BH, Chathuranga K, Uddin MB, Weeratunga P, Kim MS, Cho WK, Kim HI, Ma JY, Lee JS. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state. J Microbiol. 2017;55:488–498. doi: 10.1007/s12275-017-7088-x. [DOI] [PubMed] [Google Scholar]
  • 146.Guo S, Gao Y, Jin Y, Tian X, Cui X. The inhibitory effect of iridoid glycoside extracted from Fructus Gardeniae on intracellular acidification and extracellular Ca2+ influx induced by influenza A virus. Exp Biol Med (Maywood) 2014;239:986–997. doi: 10.1177/1535370214530361. [DOI] [PubMed] [Google Scholar]
  • 147.Guo S, Bao L, Li C, Sun J, Zhao R, Cui X. Antiviral activity of iridoid glycosides extracted from Fructus Gardeniae against influenza A virus by PACT-dependent suppression of viral RNA replication. Sci Rep. 2020;10:1897. doi: 10.1038/s41598-020-58443-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Zhang Y, Yao J, Qi X, Liu X, Lu X, Feng G. Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo. Antivir Ther. 2017;22:599–611. doi: 10.3851/IMP3152. [DOI] [PubMed] [Google Scholar]
  • 149.Yang Q, Wu B, Shi Y, Du X, Fan M, Sun Z, Cui X, Huang C. Bioactivity-guided fractionation and analysis of compounds with anti-influenza virus activity from Gardenia jasminoides Ellis. Arch Pharm Res. 2012;35:9–17. doi: 10.1007/s12272-012-0101-3. [DOI] [PubMed] [Google Scholar]
  • 150.Lin YJ, Lai CC, Lai CH, Sue SC, Lin CW, Hung CH, Lin TH, Hsu WY, Huang SM, Hung YL, Tien N, Liu X, Chen CL, Tsai FJ. Inhibition of enterovirus 71 infections and viral IRES activity by Fructus gardeniae and geniposide. Eur J Med Chem. 2013;62:206–213. doi: 10.1016/j.ejmech.2012.12.038. [DOI] [PubMed] [Google Scholar]
  • 151.Huang AG, Tan XP, Qu SY, Wang GX, Zhu B. Evaluation on the antiviral activity of genipin against white spot syndrome virus in crayfish. Fish Shellfish Immunol. 2019;93:380–386. doi: 10.1016/j.fsi.2019.07.083. [DOI] [PubMed] [Google Scholar]
  • 152.Song M, Chen Y, Du H, Zhang S, Wang Y, Zeng L, Yang J, Shi J, Wu Y, Wang D, Hu Y, Liu J. Raw Rehmannia Radix polysaccharide can effectively release peroxidative injury induced by duck hepatitis A virus. Afr J Tradit Complement Altern Med. 2017;14:8–21. doi: 10.21010/ajtcam.v14i4.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Behrendt P, Perin P, Menzel N, Banda D, Pfaender S, Alves MP, Thiel V, Meuleman P, Colpitts CC, Schang LM, Vondran FWR, Anggakusuma , Manns MP, Steinmann E, Pietschmann T. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry. Antiviral Res. 2017;147:19–28. doi: 10.1016/j.antiviral.2017.09.006. [DOI] [PubMed] [Google Scholar]
  • 154.Lam IF, Huang M, Chang MD, Yao PW, Chou YT, Ng SK, Tsai YL, Lin YC, Zhang YF, Yang XY, Lai YK. Identification of anti-HBV activities in Paeonia suffruticosa Andr. using GRP78 as a drug target on Herbochip(®) Chin Med. 2017;12:11. doi: 10.1186/s13020-017-0132-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Antonio GE, Wong KT, Hui DS, Wu A, Lee N, Yuen EH, Leung CB, Rainer TH, Cameron P, Chung SS, Sung JJ, Ahuja AT. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology. 2003;228:810–815. doi: 10.1148/radiol.2283030726. [DOI] [PubMed] [Google Scholar]
  • 156.Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020;24:176. doi: 10.1186/s13054-020-02882-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Tao J, Nie Y, Hou Y, Ma X, Ding G, Gao J, Jiang M, Bai G. Chemomics-integrated proteomics analysis of Jie-Geng-Tang to ameliorate lipopolysaccharide-induced acute lung injury in mice. Evid Based Complement Alternat Med. 2016;2016:7379146. doi: 10.1155/2016/7379146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Chai CZ, Mo WL, Zhuang XF, Kou JP, Yan YQ, Yu BY. Protective effects of Sheng-Mai-San on right ventricular dysfunction during chronic intermittent hypoxia in mice. Evid Based Complement Alternat Med. 2016;2016:4682786. doi: 10.1155/2016/4682786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Yang D, Yang X, Yan H, Fan B, Dai J, Song J, Lei Y, Guo N. UPLC-MS/MS determination of twelve ginsenosides in Shenfu Tang and Dushen Tang. Int J Anal Chem. 2019;2019:6217125. doi: 10.1155/2019/6217125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Wang GH, Lan R, Zhen XD, Zhang W, Xiang J, Cai DF. An-Gong-Niu-Huang Wan protects against cerebral ischemia induced apoptosis in rats: up-regulation of Bcl-2 and down-regulation of Bax and caspase-3. J Ethnopharmacol. 2014;154:156–162. doi: 10.1016/j.jep.2014.03.057. [DOI] [PubMed] [Google Scholar]
  • 161.Wang HM, Huang P, Li Q, Yan LL, Sun K, Yan L, Pan CS, Wei XH, Liu YY, Hu BH, Wang CS, Fan JY, Han JY. Post-treatment with Qing-Ying-Tang, a compound Chinese medicine relives lipopolysaccharide-induced cerebral microcirculation disturbance in mice. Front Physiol. 2019;10:1320. doi: 10.3389/fphys.2019.01320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Kim HM, An CS, Jung KY, Choo YK, Park JK, Nam SY. Rehmannia glutinosa inhibits tumour necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes. Pharmacol Res. 1999;40:171–176. doi: 10.1006/phrs.1999.0504. [DOI] [PubMed] [Google Scholar]
  • 163.Huang C, Wu X, Wang S, Wang W, Guo F, Chen Y, Pan B, Zhang M, Fan X. Combination of Salvia miltiorrhiza and ligustrazine attenuates bleomycin-induced pulmonary fibrosis in rats via modulating TNF-alpha and TGF-beta. Chin Med. 2018;13:36. doi: 10.1186/s13020-018-0194-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Liu M, Xu H, Zhang L, Zhang C, Yang L, Ma E, Liu L, Li Y. Salvianolic acid B inhibits myofibroblast transdifferentiation in experimental pulmonary fibrosis via the up-regulation of Nrf2. Biochem Biophys Res Commun. 2018;495:325–331. doi: 10.1016/j.bbrc.2017.11.014. [DOI] [PubMed] [Google Scholar]
  • 165.But PP, Tam YK, Lung LC. Ethnopharmacology of rhinoceros horn. II: antipyretic effects of prescriptions containing rhinoceros horn or water buffalo horn. J Ethnopharmacol. 1991;33:45–50. doi: 10.1016/0378-8741(91)90159-b. [DOI] [PubMed] [Google Scholar]
  • 166.Liu R, Wang M, Duan JA. Antipyretic and antioxidant activities of the aqueous extract of Cornu bubali (water buffalo horn) Am J Chin Med. 2010;38:293–306. doi: 10.1142/S0192415X10007853. [DOI] [PubMed] [Google Scholar]
  • 167.Kwon OG, Ku SK, An HD, Lee YJ. The effects of Platycodin D, a Saponin Purified from Platycodi Radix, on collagen-induced DBA/1J mouse rheumatoid arthritis. Evid Based Complement Alternat Med. 2014;2014:954508. doi: 10.1155/2014/954508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Choi JH, Hwang YP, Lee HS, Jeong HG. Inhibitory effect of Platycodi Radix on ovalbumin-induced airway inflammation in a murine model of asthma. Food Chem Toxicol. 2009;47:1272–1279. doi: 10.1016/j.fct.2009.02.022. [DOI] [PubMed] [Google Scholar]
  • 169.Zhang YC, Chen RM, Lu BJ, Rong YZ. Effect of Shengmai injection on cardiac function and inflammatory reaction in patients with acute coronary syndrome. Chin J Integr Med. 2008;14:107–110. doi: 10.1007/s11655-008-0107-3. [DOI] [PubMed] [Google Scholar]
  • 170.Quan FS, Compans RW, Cho YK, Kang SM. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Vaccine. 2007;25:272–282. doi: 10.1016/j.vaccine.2006.07.041. [DOI] [PubMed] [Google Scholar]
  • 171.Zhang Q, Li CS, Wang S, Gu W. Effects of Chinese medicine shen-fu injection on the expression of inflammatory cytokines and complements during post-resuscitation immune dysfunction in a porcine model. Chin J Integr Med. 2016;22:101–109. doi: 10.1007/s11655-014-1857-8. [DOI] [PubMed] [Google Scholar]
  • 172.Mou Z, Lv Z, Li Y, Wang M, Xu Q, Yu X. Clinical effect of Shenfu injection in patients with septic shock: a meta-analysis and systematic review. Evid Based Complement Alternat Med. 2015;2015:863149. doi: 10.1155/2015/863149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 173.Chai Y, Yin Z, Fan Q, Zhang Z, Ye K, Xu Y, Xiao W, Chai X, Zhu T, Nie H. Protective effects of Angong Niuhuang Pill on early atherosclerosis in ApoE(-/-) mice by reducing the inflammatory response. Evid Based Complement Alternat Med. 2019;2019:9747212. doi: 10.1155/2019/9747212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174.Guo Y, Yan S, Xu L, Zhu G, Yu X, Tong X. Use of angong niuhuang in treating central nervous system diseases and related research. Evid Based Complement Alternat Med. 2014;2014:346918. doi: 10.1155/2014/346918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175.Yu ZJ, Xu Y, Peng W, Liu YJ, Zhang JM, Li JS, Sun T, Wang P. Calculus bovis: a review of the traditional usages, origin, chemistry, pharmacological activities and toxicology. J Ethnopharmacol. 2020;254:112649. doi: 10.1016/j.jep.2020.112649. [DOI] [PubMed] [Google Scholar]
  • 176.Evaluation of the antipyretic activity of Gypsum Fibrosum and its constituents. Asian J Trad Med. 2009;4:82–84. [Google Scholar]
  • 177.European Society of Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. 2020. https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance.
  • 178.Li F, Tan YS, Chen HL, Yan Y, Zhai KF, Li DP, Kou JP, Yu BY. Identification of schisandrin as a vascular endothelium protective component in YiQiFuMai powder injection using HUVECs binding and HPLC-DAD-Q-TOF-MS/MS analysis. J Pharmacol Sci. 2015;129:1–8. doi: 10.1016/j.jphs.2015.02.003. [DOI] [PubMed] [Google Scholar]
  • 179.Xia Y, S D, Jiang S, Fan R, Wang Y, Wang Y, Tang J, Zhang Y, He RL, Yu B, Kou J. YiQiFuMai lyophilized injection attenuates particulate matter-induced acute lung injury in mice via TLR4-mTOR-autophagy pathway. Biomed Pharmacother. 2018;108:906–913. doi: 10.1016/j.biopha.2018.09.088. [DOI] [PubMed] [Google Scholar]
  • 180.Shi L, Xie Y, Liao X, Chai Y, Luo Y. Shenmai injection as an adjuvant treatment for chronic cor pulmonale heart failure: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Altern Med. 2015;15:418. doi: 10.1186/s12906-015-0939-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181.Lim RJ, Nik Nabil WN, Chan SY, Wong YF, Han LX, Gong JY, Ho KL, Shew YS, Xu L. Effects of herbal medicine for xerostomia in head and neck cancer patients: an observational study in a tertiary cancer hospital. Support Care Cancer. 2019;27:3491–3498. doi: 10.1007/s00520-019-4646-2. [DOI] [PubMed] [Google Scholar]
  • 182.Nik Nabil WN, Lim RJ, Chan SY, Lai NM, Liew AC. A systematic review on Chinese herbal treatment for radiotherapy-induced xerostomia in head and neck cancer patients. Complement Ther Clin Pract. 2018;30:6–13. doi: 10.1016/j.ctcp.2017.10.004. [DOI] [PubMed] [Google Scholar]
  • 183.Lai TY, Kuo HW. Changes in urinary Cu, Zn, and Se levels in cancer patients after treatment with Sha Shen Mai Men Dong Tang. J Tradit Complement Med. 2016;6:135–139. doi: 10.1016/j.jtcme.2014.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 184.Chen Y, Miao Y, Huang L, Li J, Sun H, Zhao Y, Yang J, Zhou W. Antioxidant activities of saponins extracted from Radix Trichosanthis: an in vivo and in vitro evaluation. BMC Complement Altern Med. 2014;14:86. doi: 10.1186/1472-6882-14-86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185.Chen Y, Sun H, Huang L, Li J, Zhou W, Chang J. Neuroprotective effect of Radix Trichosanthis Saponins on subarachnoid hemorrhage. Evid Based Complement Alternat Med. 2015;2015:313657. doi: 10.1155/2015/313657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186.Kwon DH, Cheon JM, Choi EO, Jeong JW, Lee KW, Kim KY, Kim SG, Kim S, Hong SH, Park C, Hwang HJ, Choi YH. The immunomodulatory activity of Mori folium, the leaf of Morus alba L., in RAW 264.7 macrophages in vitro. J Cancer Prev. 2016;21:144–151. doi: 10.15430/JCP.2016.21.3.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187.Wardwell LH, Huttenhower C, Garrett WS. Current concepts of the intestinal microbiota and the pathogenesis of infection. Curr Infect Dis Rep. 2011;13:28–34. doi: 10.1007/s11908-010-0147-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 188.Zhang S, Lin L, Liu W, Zou B, Cai Y, Liu D, Xiao D, Chen J, Li P, Zhong Y, Liao Q, Xie Z. Shen-Ling-Bai-Zhu-San alleviates functional dyspepsia in rats and modulates the composition of the gut microbiota. Nutr Res. 2019;71:89–99. doi: 10.1016/j.nutres.2019.10.001. [DOI] [PubMed] [Google Scholar]
  • 189.Ji HJ, Kang N, Chen T, Lv L, Ma XX, Wang FY, Tang XD. Shen-Ling-Bai-Zhu-San, a spleen-tonifying Chinese herbal formula, alleviates lactose-induced chronic diarrhea in rats. J Ethnopharmacol. 2019;231:355–362. doi: 10.1016/j.jep.2018.07.031. [DOI] [PubMed] [Google Scholar]
  • 190.Lv WJ, Liu C, Li YF, Chen WQ, Li ZQ, Li Y, Xiong Y, Chao LM, Xu XL, Guo SN. Systems pharmacology and microbiome dissection of Shen Ling Bai Zhu San reveal multiscale treatment strategy for IBD. Oxid Med Cell Longev. 2019;2019:8194804. doi: 10.1155/2019/8194804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191.Shi K, Qu L, Lin X, Xie Y, Tu J, Liu X, Zhou Z, Cao G, Li S, Liu Y. Deep-fried Atractylodis Rhizoma protects against spleen deficiency-induced diarrhea through regulating intestinal inflammatory response and gut microbiota. Int J Mol Sci. 2019;21:124. doi: 10.3390/ijms21010124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 192.Ma Q, Ouyang Y, Meng F, Noolvi MN, Avvaru SP, More UA, Aminabhavi TM, Du M, Liu H, Zhuang Y, Pang M, Cai T, Cai Y. A review of pharmacological and clinical studies on the application of Shenling Baizhu San in treatment of ulcerative colitis. J Ethnopharmacol. 2019;244:112105. doi: 10.1016/j.jep.2019.112105. [DOI] [PubMed] [Google Scholar]
  • 193.Li LC, Kan LD. Traditional Chinese medicine for pulmonary fibrosis therapy: progress and future prospects. J Ethnopharmacol. 2017;198:45–63. doi: 10.1016/j.jep.2016.12.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 194.Sun GX. Efficacy and safety of carthamin yellow sodium chloride injection combined with methylprednisolone in the treatment of idiopathic pulmonary fibrosis. J Clin Med Pract. 2016;20:46–49. [Google Scholar]
  • 195.He H, Tang H, Gao L, Wu Y, Feng Z, Lin H, Wu T. Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats. Mol Med Rep. 2015;11:4190–4196. doi: 10.3892/mmr.2015.3333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196.Wu H, Li Y, Wang Y, Xu D, Li C, Liu M, Sun X, Li Z. Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/angiotensin-(1-7) axis in rats. Int J Med Sci. 2014;11:578–586. doi: 10.7150/ijms.8365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 197.Wu Z, Zhao X, Miyamoto A, Zhao S, Liu C, Zheng W, Wang H. Effects of steroidal saponins extract from Ophiopogon japonicus root ameliorates doxorubicin-induced chronic heart failure by inhibiting oxidative stress and inflammatory response. Pharm Biol. 2019;57:176–183. doi: 10.1080/13880209.2019.1577467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198.Zhao JW, Chen DS, Deng CS, Wang Q, Zhu W, Lin L. Evaluation of anti-inflammatory activity of compounds isolated from the rhizome of Ophiopogon japonicas. BMC Complement Altern Med. 2017;17:7. doi: 10.1186/s12906-016-1539-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 199.Fang J, Wang X, Lu M, He X, Yang X. Recent advances in polysaccharides from Ophiopogon japonicus and Liriope spicata var. prolifera. Int J Biol Macromol. 2018;114:1257–1266. doi: 10.1016/j.ijbiomac.2018.04.022. [DOI] [PubMed] [Google Scholar]
  • 200.Chen MH, Chen XJ, Wang M, Lin LG, Wang YT. Ophiopogon japonicus--A phytochemical, ethnomedicinal and pharmacological review. J Ethnopharmacol. 2016;181:193–213. doi: 10.1016/j.jep.2016.01.037. [DOI] [PubMed] [Google Scholar]
  • 201.He X, Fang J, Ruan Y, Wang X, Sun Y, Wu N, Zhao Z, Chang Y, Ning N, Guo H, Huang L. Structures, bioactivities and future prospective of polysaccharides from Morus alba (white mulberry): a review. Food Chem. 2018;245:899–910. doi: 10.1016/j.foodchem.2017.11.084. [DOI] [PubMed] [Google Scholar]
  • 202.Zhu B, Zhang QL, Hua JW, Cheng WL, Qin LP. The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: a review. J Ethnopharmacol. 2018;226:143–167. doi: 10.1016/j.jep.2018.08.023. [DOI] [PubMed] [Google Scholar]
  • 203.Zhang C, Zheng Y, Chen T, Wang S, Xu M. The utility of traditional Chinese medicine (Shenmai) in the cardiac rehabilitation after coronary artery bypass grafting: a single-center randomized clinical trial. Complement Ther Med. 2019;47:102203. doi: 10.1016/j.ctim.2019.102203. [DOI] [PubMed] [Google Scholar]
  • 204.Zhang Y, Zhang L, Zhang Y, Fan X, Yang W, Yu B, Kou J, Li F. YiQiFuMai powder injection attenuates coronary artery ligation-induced heart failure through improving mitochondrial function via regulating ROS generation and CaMKII signaling pathways. Front Pharmacol. 2019;10:381. doi: 10.3389/fphar.2019.00381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 205.Zhang S, You ZQ, Yang L, Li LL, Wu YP, Gu LQ, Xin YF. Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators. BMC Complement Altern Med. 2019;19:317. doi: 10.1186/s12906-019-2686-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 206.Zhang K, Zhang J, Wang X, Wang L, Pugliese M, Passantino A, Li J. Cardioprotection of Sheng Mai Yin a classic formula on adriamycin induced myocardial injury in Wistar rats. Phytomedicine. 2018;38:1–11. doi: 10.1016/j.phymed.2017.09.001. [DOI] [PubMed] [Google Scholar]
  • 207.Ma S, Li X, Dong L, Zhu J, Zhang H, Jia Y. Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats. BMC Complement Altern Med. 2016;16:61. doi: 10.1186/s12906-016-1037-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ajcr0010-2010-f1.pdf (181.9KB, pdf)

Articles from American Journal of Cancer Research are provided here courtesy of e-Century Publishing Corporation

RESOURCES